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Defining The Difficult-To-Sedate Clinical Phenotype In Critically Ill Children
Abstract
Each year thousands of critically-ill children receive sedation to help them tolerate intensive care
therapies. A significant number of these children do not respond as expected to appropriately dosed
sedation and remain agitated for some period, leading to iatrogenic injury and increased stress, as well as
increased resource use. Children who remain under-sedated despite optimal therapy are considered
“difficult-to-sedate”, but, to date, little data have been available to support an accurate description of this
group of children. Recent attention to heterogeneity of treatment effect has spurred the development of
clinical phenotypes that describe subgroups of patients within a disease process who differ in their
clinical attributes and responses to therapy. Defining the difficult-to-sedate clinical phenotype in critically
ill children is important because it will allow the use of sedation therapy targeted to the unique clinical,
physiological, and developmental characteristics of the child.
The three papers developed in this dissertation study explored the concept of the difficult-to-sedate child
clinical phenotype. A comprehensive review of the literature identified the lack of an operational definition
and identified factors contributing to the clinical phenotype. These factors were used to develop an initial
operational definition and to construct a conceptual model. Expert critical care clinicians validated the
elements of the operational definition through an assessment of face and content validity and proposed
additional factors for inclusion in the model. A refined definition was tested using data from the RESTORE
study. Characteristics identified through latent class and classification and regression tree analysis were
consistent with the conceptual model proposed.
Decreasing the ambiguity that currently exists around the concept of the difficult-to-sedate child clinical
phenotype is a major achievement of this study. A clear operational definition of the concept promotes its
consistent measurement and facilitates future investigation, and allows useful comparisons across
studies. The conceptual model and operational definition require further investigation and refinement, as
well as prospective validation by other investigators. This study suggests that a clinically meaningful
population of difficult-to-sedate children requiring mechanical ventilation for a critical illness exists.
Documentation of this phenotype promotes the development of evidence to support best practices in the
care of these children.
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ABSTRACT
DEFINING THE DIFFICULT-TO-SEDATE CLINICAL PHENOTYPE
IN CRITICALLY ILL CHILDREN
Ruth M. Lebet
Martha A. Q. Curley, PhD, RN
Each year thousands of critically-ill children receive sedation to help them
tolerate intensive care therapies. A significant number of these children do not
respond as expected to appropriately dosed sedation and remain agitated for
some period, leading to iatrogenic injury and increased stress, as well as
increased resource use. Children who remain under-sedated despite optimal
therapy are considered “difficult-to-sedate”, but, to date, little data have been
available to support an accurate description of this group of children. Recent
attention to heterogeneity of treatment effect has spurred the development of
clinical phenotypes that describe subgroups of patients within a disease process
who differ in their clinical attributes and responses to therapy. Defining the
difficult-to-sedate clinical phenotype in critically ill children is important because it
will allow the use of sedation therapy targeted to the unique clinical,
physiological, and developmental characteristics of the child.
The three papers developed in this dissertation study explored the concept of the
difficult-to-sedate child clinical phenotype. A comprehensive review of the
literature identified the lack of an operational definition and identified factors
contributing to the clinical phenotype. These factors were used to develop an
initial operational definition and to construct a conceptual model. Expert critical
care clinicians validated the elements of the operational definition through an
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assessment of face and content validity and proposed additional factors for
inclusion in the model. A refined definition was tested using data from the
RESTORE study. Characteristics identified through latent class and
classification and regression tree analysis were consistent with the conceptual
model proposed.
Decreasing the ambiguity that currently exists around the concept of the difficultto-sedate child clinical phenotype is a major achievement of this study. A clear
operational definition of the concept promotes its consistent measurement and
facilitates future investigation, and allows useful comparisons across studies.
The conceptual model and operational definition require further investigation and
refinement, as well as prospective validation by other investigators. This study
suggests that a clinically meaningful population of difficult-to-sedate children
requiring mechanical ventilation for a critical illness exists. Documentation of this
phenotype promotes the development of evidence to support best practices in
the care of these children.

v

TABLE OF CONTENTS

DEDICATION……………………………………………………………………….…..ii
ACKNOWLEDGEMENT………………………………………………………………iii
ABSTRACT……………………………………………………………………..………iv
TABLE OF CONTENTS……………………………………………………………….vi
LIST OF TABLES……………………………………………………………..……...viii
LIST OF ILLUSTRATIONS…………………………………………………………….x
CHAPTER 1……………………………………………………………………………..1
Introduction………………………………………………………………………………….…………….1
Background……………………………………………………………………………….……………….5
Developmental Issues Related to Sedation……………………………………….…………………6
Sedation Assessment Tools………………………………………………………….……………….13
Clinical Phenotypes……………………………………………………………….…………………….16
Significance………………………………………………………………………….…………………...20
Dissertation Format……………………………………………………………………………….…….22
Chapter 2………………………………………………………………………………………………22
Chapter 3………………………………………………………………………………………………24
Chapter 4………………………………………………………………………………………………27
Limits, Assumptions and Design Controls……………………………….………………………...30
Appendices.………………………………………………………………………….…………………...34
References………………………………………………………………………………………………..39

CHAPTER 2……………………………………………………………………………54
Abstract………………………………………………………………………………….………………..56
Methods…………….……………………………………………………………….…………………….57
Sample Cases...………….………………………………………………………….…………………...63
Antecedents and Consequences……………………………………………………………….…….66
Conceptual Model………………………………………………………………...……………………..68
Discussion………………………………………………………………………………………………..68
References………………………………………………………………………………………………..72

vi

Tables…….……………………………………………………………………………………………..…80
Figures…………………………………………………………………………………………………….88

CHAPTER 3……………………………………………………………………………91
Abstract………………………………………………………………………………….………………..93
Introduction…………………..………………………………………………………….……………….95
Methods…………….……………………………………………………………….……………..……...99
Results………...………….………………………………………………………….……………….....102
Discussion………………………………………………………………………………………………104
Conclusions……..…………………………………………………………………………………...…106
References………………………………………………………………………………………………108
Tables…….………………………………………………………………………………………………113
Appendices………………………………………………………………………………………...……119

CHAPTER 4……………………………………………………………………..……123
Abstract………………………………………………………………………………….…………..…..124
Introduction…………………..………………………………………………………….…………..….125
Methods…………….……………………………………………………………….………………..….126
Results………...………….………………………………………………………….………..………...129
Discussion…………………………………………………………………………………………...….131
Conclusions……..………………………………………………………………………………..…….136
References………………………………………………………………………………………………137
Tables…….………………………………………………………………………………………………142
Figures…………………………………………………………………………………………………...146
Supplemental Materials………………………………………………………………………..……..150

CHAPTER 5…………………………………………………………………………..156
Principal Findings…………….……………………………………………….……………………….157
Limitations………...….………………………………………………………….…………………......163
Directions for Future Research……………………………………………………………….…….164
Conclusions……..………………………………………………………………………………...……166
References……………………………………………………………………………………………....168

BIBLIOGRAPHY…………………………………………………………………..…170

vii

LIST OF TABLES
CHAPTER 1
Table 1: Medications Frequently Used for Sedation in the Pediatric
Intensive Care Unit
Table 2: Sedation Scoring Tools used in the Pediatric Intensive Care Unit
Table 3: Manuscripts and Specific Aims
Table 4: Operational Definitions
Table 5: Variability in Sedation Response of Subjects Enrolled in the
RESTORE (Parent) Study
CHAPTER 2
Table 1: Search Strategy
Table 2: Studies Evaluated
CHAPTER 3
Table 1: Survey Response Details
Table 2. Difficult-to-Sedate Criteria: Mean Score and Item-level Content
Validity Index (I-CVI)
Table 3. Summary of Free-Text Responses
CHAPTER 4
Table 1: Demographic and Patient Characteristics of Sample by Outcome
First Three Days of Therapy for the LCA & CART
Table 2: Fit Statistics for Latent Class Models For 2 to 4 Class Models By
Group
Table 3: Test Characteristics of the Decision Tree
viii

Supplementary Tables
STable 1: Variables Included in the Difficult-to-Sedate Analysis Linked to
the Survey of Expert PICU Clinicians
STable 2: Characteristics of the Parent Study Cohort by Group

ix

LIST OF ILLUSTRATIONS
CHAPTER 2
Figure 1: PRISMA Flow Diagram
Box 1: Sequential Steps in the Walker & Avant Method of Concept
Analysis
Figure 2: Conceptual Model
CHAPTER 3
Appendix A. Text of PALISI and SCCM Survey Participation Request
Emails
Appendix B. Difficult to Sedate Survey (SCCM Version)
CHAPTER 4
Figure 1: Comparison of Latent Class and Classification and Regression
Tree Methodologies
Figure 2: Latent Class Analysis: Probability of Characteristics by
Phenotype Assignment
Figure 3: CART Decision Tree for Difficult-to-sedate Clinical Phenotype
Supplement Figure 1: CART Variables of Importance

x

Chapter 1
Introduction
The Problem
Each year more than 115,000 critically-ill children receive sedation to help them
tolerate intubation and mechanical ventilation.1 A significant number of these children do
not respond as expected to appropriately dosed sedation and remain agitated for some
period of time, leading to iatrogenic injury and increased stress.2-5 Over the course of the
critical care admission, children who remain under-sedated despite optimal therapy are
considered by the clinical team to be difficult-to-sedate, but little is known about this
group of children to allow prospective identification. By the time the child is identified as
difficult-to-sedate, excessive and potentially avoidable burden has been placed on the
child and family; resource requirements to ensure the child’s safety have increased; and
injury may have occurred.
Prospective identification of these children has been hampered by a variety of
factors. Intensive care sedation is a complex phenomenon, impacted by multiple
variables. Easily implemented, valid and reliable instruments that describe sedation
levels in children have only become available and widely used in the last decade. The
age range of the patients cared for in the pediatric intensive care unit (PICU) is wide and
encompasses enormous physiological and psychosocial differences. Although well
studied in adults, there are limited data on the metabolism and elimination of drugs
commonly used for sedation in children.6,7 Organ maturation and critical illness also
affect the rate at which sedation medications are metabolized and eliminated from the
body. The influence of psychosocial development in response to sedation has not been
thoroughly described. There may be a genetic basis8 for the difficult-to-sedate child.
Finally, the unit-specific context in which the sedation is provided is important. Each
1

PICU’s environment influences how and when sedation is delivered, the specific agents
used to provide sedation, as well as the definition of appropriate or optimal levels of
sedation. Each of these factors combine to make studying the phenomenon of sedation
in critically ill children challenging.
Defining sedation-related clinical phenotypes in critically ill children would
facilitate better clinical management of these patients while avoiding harm. Specifically,
accurate prediction of an individual child’s response to sedation would allow the
selection of individualized therapy and contribute to improved clinical outcomes.
Jameson and Longo,9 in their discussion of precision medicine, acknowledge the
contribution of phenotype: “treatments targeted to the needs of individual patients on the
basis of genetic, biomarker, phenotypic or psychosocial characteristics that distinguish a
given patient from other patients with similar clinical presentations”. High doses of
sedatives, and the simultaneous use of multiple agents, as typically occurs in the difficult
to sedate child, generally results in significant side effects. Identifying and providing
targeted sedation strategies most effective for the difficult-to- sedate child will avoid
these side effects.
To date, the difficult-to-sedate child clinical phenotype has not been described. In
other populations, advanced statistical methods have been used to analyze large
datasets and identify different phenotypes within a specific disease process. Howrylak
and colleagues10 provide one example. They examined clinical data from 1041 children
with asthma using cluster analysis to identify differences between clusters in terms of
pulmonary function and response to inhaled anti-inflammatory medication. Five patient
clusters were identified based on differences in three features. They identified that
membership in a specific cluster predicted the child’s long-term asthma control and that
two clusters which had the highest exacerbation rates responded differently to inhaled
2

corticosteroids. The authors concluded that phenotypic clustering effectively identified
consistent and clinically relevant patient subgroups, with implications for targeted
therapies.
Using latent class modeling, Calfee et al11 analyzed data for 1022 subjects
enrolled in two randomized controlled trials investigating acute respiratory distress
syndrome. They identified two phenotypes within the population which had differing
clinical and biological characteristics, differing responses to treatment, and differing
outcomes. Members of phenotype 2 had severe shock, metabolic acidosis, high
vasopressor use and higher levels of inflammatory biomarkers. They also had worse
outcomes.
In the case of intubated and sedated children, the difficult-to-sedate child clinical
phenotype might include a combination of demographic, physiological and
developmental factors.12-14 Concept analysis is an ideal methodology to identify
candidate variables key to describing the clinical phenotype. The purpose of identifying a
concept (what something is or how it works) is to develop a mechanism to describe and
illuminate a phenomenon of interest. Walker and Avant15 have developed and refined a
process through several iterations which provides a systematic and thoughtful
mechanism to achieve that goal. An important aspect of their method is that after a
concept is identified, it must be clarified to clearly differentiate it from other concepts.
This is done through careful examination of the structure and function of the concept.
This requires examination of a concept’s basic, essential elements in order to develop a
clear, precise operational definition of the concept of interest.
This dissertation seeks to provide a comprehensive description of a clinical
phenotype of critically ill children who demonstrate an under-sedation response,
specifically, the difficult-to-sedate child clinical phenotype.
3

The specific aims for this dissertation are as follows:
1) To explore key variables thought to be associated with the difficult-to-sedate
child, propose a conceptual model linking those variables in critically ill
pediatric patients, and develop an operational definition of the difficult-tosedate child. (Method: Concept analysis that includes a systematic review of
the literature)
2) To assess both face and content validity of the candidate variables identified
through the systematic review and incorporated in a preliminary model.
(Method: Survey of the Pediatric Acute Lung Injury and Sepsis Investigators
(PALISI Network and the Society of Critical Care Medicine (SCCM) Pediatric
Sedation Study Group)
3) To build and test a statistical model describing the difficult-to-sedate child
clinical phenotype. (Method: Statistical modeling of an existing clinical dataset
of 2449 critically ill children)
Hypothesis: The difficult-to-sedate clinical phenotype can be described in
critically ill children.

Approach
The overall strategy for this dissertation will be: 1) to complete a concept analysis
using the methodology described by Walker and Avant15 that includes a systematic
review of the pertinent literature resulting in a clear operational definition and framework
of the difficult-to-sedate child clinical phenotype. The definition proposed in the current
chapter will be modified based on the findings from the concept analysis. The
operational definition and framework ultimately will be used to construct a statistical
model which describes the key factors impacting the level of sedation achieved in
critically ill children; 2) to establish face and content validity of the candidate variables
4

identified and explore additional unpublished variables to be incorporated in the model
through a survey of expert pediatric critical care clinicians; and 3) to build and test the
final model constructed using an existing clinical dataset of 2449 critically ill children.
The methodology, and analyses to be used to accomplish the specific aims of this
project are described below.
Three benchmarks for success have been identified as necessary to achieve the
aims of this dissertation. The first is completion of the systematic literature review, which
will direct the initial model design. The second benchmark will be achievement of a
survey return rate of at least 50%, with attainment of an acceptable content validity index
for at least half of the variables contained in the initial model and refinement of the initial
model. The final benchmark will be the statistical model describing the difficult-to-sedate
clinical phenotype.

Background
Pediatric intensive care units (PICU) were developed to provide care to critically
ill infants and children in a developmentally appropriate setting with a care team skilled
in working with these patients. One of the most common therapies provided in the PICU
is invasive mechanical ventilation.16-21 It is difficult for children to understand and
cooperate with this therapy, so they receive sedation to ensure safety, decrease fear
and anxiety and promote comfort.22-27 Doses for sedation agents have generally been
extrapolated from adult doses and sedation practices vary greatly between PICUs.22,26-30
A small number of studies have identified developmental differences in both the
pharmacokinetics and pharmacodynamics of drugs in children.6,30-37
When children are sedated, effectiveness of sedation is generally assessed to
ensure the target sedation level is achieved. Use of objective monitors of sedation level,
such as the Bispectral index (BIS) monitor have not correlated well with clinical
5

assessment of sedation level in critically ill children, so observational sedation
assessment tools are generally used.38-41 Reliable and valid pediatric specific sedation
assessment tools have been developed in the last ten years. Prior to their availability
modified adult sedation assessment tools were used in most studies of critically ill
children receiving sedation.42-47 When sedation targets are not achieved, children are at
risk for adverse events such as unplanned extubation.4,48 Children who will be difficult-tosedate cannot be prospectively identified based on current knowledge. One mechanism
which shows promise is clinical phenotype identification. Clinical phenotypes group
patients by presentation and response to therapy, and facilitate the delivery of
individualized and effective therapy. In contrast, biological phenotypes consider specific,
measurable biological abnormalities and may be determined by a single specific
abnormality, such as rate of drug metabolism. Currently, there is no way to
prospectively identify either the clinical or biological phenotype of the difficult-to-sedate
child. Clinical phenotype identification is highly aligned with the National priority of
Precision Medicine.
PICUs across the US are a very heterogeneous group. They vary dramatically
on factors such as number of beds, availability of specialty services, ability to provide
highly technical services such as renal replacement therapy or extracorporeal
membrane oxygenation, and the educational preparation of nursing staff. However, one
element universal to all PICUs is that all provide mechanical ventilation to patients on a
daily basis. Each year thousands of children are admitted to PICUs in the United States
due to a critical illness or injury which requires endotracheal intubation to facilitate
mechanical ventilation.17-20 At least 30% of children admitted to PICUs receive
mechanical ventilation.1,17,18 The majority of these children receive sedation therapy to
keep them safe, prevent patient-ventilator dyssynchrony and minimize the negative
6

effects of painful procedures and the often unpredictable and frightening
environment.22,23,25-27 Appropriate levels of sedation change over the course of the child’s
illness and are impacted by both anticipated and unanticipated events for the patient,
such as transport off of the unit for tests and procedures.
Sedation Agents
Several surveys provide a description of the evolution of sedation practices in the
PICU over time.23,24,26,27,29,49 In 1989 Marx and colleagues24 surveyed the directors of
Pediatric Critical Care training programs in the United States and Canada to identify the
sedative agents used and methods of delivery. In total, 35 surveys representing a 75%
response rate, were received. At that point in time, opioids, benzodiazepines and chloral
hydrate were identified as the most frequently used agents, and typically opioids and
benzodiazepines were used in combination. The most frequent mode of administration
was intermittent dosing on an as needed basis. Other adjunctive medications such as
ketamine and barbiturates (e.g. thiopental, pentobarbital) were used less frequently, and
generally for sedation related to procedures. Few units identified a written protocol for
sedation (5.9%). The primary goals of sedation use were to increase comfort and
prevent unplanned extubation. Interestingly, respondents reported the “biggest problem”
with sedation to be inadequate efficacy.24
In 1997 Rhoney et al26 surveyed all pediatric attending physician members of the
Society of Critical Care Medicine on their use of sedative and neuromuscular blocking
agents. The response rate was 51%, 145 pediatric critical care units were represented,
and the findings were similar to those of Marx and colleagues. Opioids and
benzodiazepines were the drugs most often used for sedation, given as continuous
infusion or intermittent bolus dose. Drugs indicated as being “routinely” used for
sedation, in order of frequency, included fentanyl, midazolam, morphine and lorazepam.
7

Adjunctive medications such as ketamine, chloral hydrate and propofol were
“occasionally” used. The indications cited most often for use of sedation were
management of anxiety and fear, amnesia, and facilitating mechanical ventilation. A
sedation protocol was used in 13% of units. A sedation scale was used to monitor the
level of sedation in 36% of units, almost equally divided between the COMFORT scale42
and a scale developed by the respondent’s institution.
In 2003 Twite et al27 surveyed Fellowship directors at 59 pediatric critical care
training programs in the United States. The return rate was 60%; 35 surveys were
received. Agents used for sedation were similar, but the ranking of those most
frequently used sedatives had changed. Midazolam, rather than morphine was the most
frequently used agent, with lorazepam second in frequency of use, and morphine third.
These medications were most frequently delivered as continuous infusions, with both a
sedative and analgesic being administered simultaneously. Chloral hydrate use had
decreased from 68% of respondents reporting “frequent” use to 37% of respondents.
Propofol and dexmedetomidine became available in the interval between the two
surveys, and propofol in particular was used regularly. “Frequent” propofol use was
reported by 29% of respondents, while only 3% of respondents reported frequent use of
dexmedetomidine. Of note, 49% of units reported regular use of patient controlled
analgesia. Use of adjunctive medications continued, most commonly to manage
medication withdrawal symptoms. The number of units with a written sedation protocol
increased from 5.9% to 66%. Overall satisfaction with the ability to provide optimal
sedation increased compared to the previous survey, with respondents indicating that
children were mainly “occasionally” difficult-to-sedate.
Kudchadkar23 and colleagues surveyed an international sample of PICU
intensivists, fellows, nurse practitioners and nurses. The majority of the respondents
8

(70%) were from North American and were pediatric intensivists (also 70%). Data were
collected from July 2012 through January 2013. The authors separate out data for North
American respondents (n= 225) and those data are reported here, as there was
variability between North American sites and all other countries in primary agent used,
sleep promotion techniques, frequency of delirium assessment, and the study population
used in this dissertation is drawn from the United States. Availability of a sedation
protocol was identified in this survey as 20% of PICUs, although this survey defined a
sedation protocol as including a treatment algorithm, which is a more specific criterion
than the two previous surveys. Fentanyl and midazolam were the two most frequently
used agents, at 76% and 82% respectively, and were generally used in tandem.
Continuous infusion as the method of delivery was by far the most frequent choice, at
80%. Scheduled intermittent dosing was used by 10% of units. The regular use of
dexmedetomidine increased to 10%. This survey also reported on which team member
managed the sedation protocol, and 58% of units reported using a nurse-managed
protocol. A frequently identified frustration was inconsistency between team members in
sedation goals. Although the method of distribution and roles of individuals completing
the survey varied significantly from the previously reported surveys, comparison of
sedation practices over time shows an increased use of synthetic opioids (i.e., fentanyl),
increased use of midazolam, and continuous infusion as the strongly preferred mode of
sedation medication delivery.
Review of the literature over this period demonstrates the continued use of
adjunctive agents and the search for newer agents less likely to result in tolerance and
iatrogenic withdrawal syndrome. Dexmedetomidine50-57, propofol58-61, and clonidine62
have been the subject of a few clinical trials. Whalen57 reported that dexmedetomidine
was most frequently used when the desired sedation target was not able to be met using
9

opioids and benzodiazepines. Ketamine, clonidine and pentobarbital are also frequently
added as additional sedatives when opioids and benzodiazepines have been escalated
to high doses due to tolerance or when sedation targets have not been achieved. Other
drugs which continue to be used as adjunctive sedation agents are diphenhydramine,
lorazepam and chloral hydrate.
A major concern with the use of propofol in critically ill children is the significant
incidence of propofol infusion syndrome, which manifests as bradycardia, renal failure
and severe lactic acidosis. It is thought to be related to long-term use of the drug.
Propofol infusion syndrome has resulted in several pediatric deaths.63 As a result, the
FDA required a Black Box warning, it’s highest level of warning which indicates a serious
or life-threatening risk, for propofol related to pediatric use. The propofol package insert
indicates “Propofol injectable emulsion is not indicated for use in Pediatric ICU sedation
since the safety of this regimen has not been established. (See PRECAUTIONS Pediatric Use.)”64 However both propofol and dexmedetomidine are often used as a
bridge to extubation. For example, these drugs, which have a short half-life, are started
as a continuous infusion in the hours prior to a planned extubation, allowing longer
acting sedation agents to be weaned in preparation for extubation while maintaining an
acceptable level of sedation.61,65,66 This strategy is often used with children who do not
tolerate being awake and mechanically ventilated. The duration of infusion in this
situation is recommended to be 12 hours or less. Table 1 describes medications
commonly used for sedation in the PICU

Developmental Issues and Child Characteristics Related to Sedation
There have been a limited number of studies done to establish the
pharmacokinetic and pharmacodynamics properties of most of the agents used to
provide sedation to critically ill pediatric patients. Up to 80% of the drugs prescribed to
10

hospitalized infants and children are prescribed “off label,” meaning there is a lack of
evidence to support their safety and efficacy in pediatric patients.7,28,29 When identifying
appropriate dosing of sedation agents, pediatric prescribers generally extrapolate a dose
from the recommended adult dose. This practice assumes that the relationship between
drug dose and drug concentration (i.e., pharmacokinetics [PK]) and drug dose and drug
effect (i.e., pharmacodynamics [PD]) is the same in infants, children and adults.28,67
The PK and PD studies that have been carried out in both healthy and critically ill
pediatric patients generally show that there is a difference in drug clearance, elimination,
and response between neonates, infants, children and adolescents.6,30,31-37,68 However
the number of subjects enrolled in these pediatric studies is generally very small, limiting
the generalizability of findings.57,67-69 For example, four studies of midazolam PK and PD
in critically ill infants and children reported in the period between 2002 and 2008
included a total of 15 pediatric subjects.33,34,68,70 Factors related to changes in growth and
maturation of organs and physiologic systems such as protein expression and protein
function drive these differences.6,28,30
Maturation may increase or decrease drug receptor affinity for a particular drug
and may alter signal transduction.6,71 Changes in body composition, such as the
decrease in total body water or increase in adipose stores that occur as a child grows,
affect drug distribution and availability.30,71 For example, neonates and young infants
have lower adipose stores than older infants and children, and the adipose tissue of
neonates has a higher ratio of water to lipid.6 As a result, neonates and young infants
have a decreased volume of distribution of lipophilic drugs such as midazolam or
fentanyl. Thus, they will have a higher peak drug concentration than older children in
response to the same dose.67 Maturation of drug metabolizing enzyme pathways and
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increasing renal function with greater age also account for variability in the PK or PD of
specific drugs.6,30,67,71
Midazolam clearance is decreased in infants. The clearance rate increases with
age, and a clearance rate similar to adults is seen at around 5 years of age.67 deGast
Bakker33 and colleagues identified that one to four year olds required higher midazolam
doses per kilogram of body weight than other age groups. Morphine clearance in infants
is approximately 80% of that seen in adults. As a result, an increase in dose per
kilogram from 5 mcg/kg at birth to 18 mcg/kg at 1 year is required to achieve steady
state serum levels.31 Fentanyl also has a higher clearance rate in infants and children.72
Pentobarbital PD and PK are affected by both age and weight36 and pentobarbital halflife is significantly longer in neonates and infants.72 Critical illness compounds these
developmentally driven effects. For example, Ince68 and colleagues found decreased
midazolam clearance in critically ill children compared with pediatric oncology patients
receiving procedural sedation and healthy infants receiving postoperative sedation.
In addition, sedative use in infants and young children has been associated with
long-term cognitive dysfunction. Few well-designed studies that can link specific
sedation agents to cognitive outcomes have been completed to date, and results of
some studies have been contradictory. 73-78 Studies of anesthetic agents are currently
underway, as are studies examining cognitive outcomes in children who received
sedation during a PICU admission. This will be an important area of investigation to
follow as findings will impact sedation practices in the future.
Little research has been done in the area of psychosocial development and its
relationship to sedation outcomes. A child’s ability to manage negative stress and the
coping strategies employed change as the child develops, and is linked to the child’s
ability to comprehend the current situation.79 Innate child characteristics may also impact
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response to sedation. A single study linking child temperament to sedation outcome in
the setting of procedural sedation demonstrated that inflexible temperament was a
predictor of sedation failure.80 Although not commonly assessed, obtaining information
on temperament or coping behaviors from parents of critically ill children could be an
interesting area of investigation, and add to the characterization of the difficult-to-sedate
child.

Sedation Assessment Tools
Several pediatric sedation scoring tools have been developed, and are used in
PICUs across the US and internationally. Commonly used tools include the State
Behavioral Scale (SBS),43 COMFORT Scale,42 COMFORT-B scale,44 Motor Activity
Assessment Scale,81 and the Pediatric Sedation-Agitation Scale.45 The previously
referenced sedation practices surveys demonstrated the development and increased
use of validated pediatric sedation assessment tools over time.23,24,26,27 The 1989 survey
by Marx et al24 did not reference an assessment tool at all. Clinical impression of the
physician and nurse were the most frequent mechanism of assessment, with
assessment of vital signs and response to procedures also considered. In the 2003
survey, Twite27 et al included both analgesia and sedation scoring tools. Both adult and
pediatric tools were being utilized. The pediatric specific COMFORT score was the most
commonly used tool (49%), followed by the adult Motor Activity Assessment Scale
(11%). The 2013 survey23 is reflective of current practice. Pediatric specific sedation
scoring tools are most commonly used, with 22% of PICUs reporting use of the State
Behavioral Scale and 21% reporting use of the COMFORT scale, although 21% of
PICUs continue to use the Richmond Agitation-Sedation Scale, a tool validated only in
adult patients (e.g, RASS).82 Table 2 provides a description of sedation tools commonly
used in the PICU.
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Adequate and inadequate sedation exist along a continuum, and despite the
development of valid and reliable instruments to assess sedation, assessment of
adequacy of sedation is subjective. Although work is ongoing to develop an objective
measure of level of sedation, such as the BIS monitor, SNAP II (Stryker, Kalamazoo, MI)
or auditory-evoked potentials no objective measures have proved reliable and consistent
in the PICU population.38-41 There is strong evidence that sedation practices are
influenced by personal, social, and professional factors.83-86 Variability in assessment of
level of sedation is frequently seen in children who are moderately to deeply sedated,
and this is seen when raters are of the same or different provider categories.40
At the other end of the spectrum, assessment of children who are not well
sedated and are in fact agitated generally shows more consistency. This is can be
related to the use of sedation as a means to protect children who are unable to tolerate
the intensive care environment and are perceived to be in an unsafe state. Terms such
as refractory agitation, sub-optimal sedation, inadequate sedation and under-sedation
are used to describe children at this end of the sedation spectrum.87-89 The scales used
to describe level of sedation use terms such as “intermittently unsafe” or “unsafe (biting
endotracheal tube, pulling at catheters, cannot be left alone”,43 “panicky”,42 “pulls on or
removes tube(s) or catheter(s) or has aggressive behaviors toward staff” or “cannot be
left alone”,82 “dangerously agitated, uncooperative- patient is pulling at tubes or
catheters OR thrashing side to side OR striking at staff OR trying to climb out of bed”,81
and “dangerous agitation- pulling at endotracheal tube, thrashing side to side, climbing
over bedrails, hitting or kicking at staff, yelling or screaming at staff”.45 Children who are
at this end of the sedation spectrum raise significant levels of concern for parents, who
worry that children will injure themselves and who also perceive their child as suffering.
Agitated children increase the level of concern for care providers as well, who are
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concerned that the child will suffer physical harm, physiologically decompensate, remove
invasive tubes or catheters that will be difficult to replace, or possibly suffer long-term
psychological consequences of their agitated state. Children who are inadequately
sedated may remain in this state for significant amounts of time, despite regular
adjustment and addition of medications, requiring increased staff resources to ensure all
patients receive the needed attention.
Clinical states associated with ongoing agitation, such as hypoxia, pain, delirium
and children near the end of life,88-91 have been identified but there are very little data on
factors which predict children who will become and remain agitated, despite aggressive
treatment.

Adverse Events Related to Under-sedation
Despite the best efforts of the care team, up to 24% of children fail to respond to
usual sedation therapy and will require higher dosages and sedative drugs from three or
more drug classes in order to achieve the desired level of sedation.89,92 High dosages
and the use of multiple sedative agents (i.e., polypharmacy) place these children at
significant risk for sedation-related adverse events such as iatrogenic withdrawal
syndrome, infection and pressure ulcers.
During the startup phase of the RESTORE study, Grant,4 et al completed a
systematic review in order to define and provide estimates of PICU specific sedationrelated adverse events (AE). Of the eleven AE identified, five were directly related to
agitation. Inadequate sedation management was defined as “Agitation defined by an
SBS > 0 (or “assumed agitation present” in patients receiving neuromuscular blockade)
for 2 consecutive hours not related to a planned extubation attempt” (p. 1318). Based
on their systematic review the event rate for this AE was estimated as expected in less
than 10% of patients. Clinically significant iatrogenic withdrawal was expected to occur
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in less than 75% of patients. Unplanned endotracheal tube removal had an expected
event rate of less than 3.0 per 100 ventilator days. Unplanned removal of any invasive
tube could not be estimated but was tracked as an anticipated AE. Ventilator-associated
pneumonia was identified as a sedation related AE with an expected event rate of less
than 3.2 infections per 1000 ventilator days. New tracheostomies were tracked as a
marker for extreme airway trauma secondary to agitation.
These sedation-related AEs are also supported by more recent work. Payen5 et
al identified the use of continuous intravenous sedation as a risk factor associated with
prolonged invasive mechanical ventilation in critically ill children, which in turn is
associated with increased morbidity and mortality. Gautam3 and colleagues identified a
relationship between ventilator-associated pneumonia and prolonged invasive
mechanical ventilation in pediatric patients. Best2 et al. identified duration and cumulative
dose of opioid and benzodiazepine therapy as risk factors for iatrogenic withdrawal
syndrome in critically ill pediatric patients.
After initiation of the RESTORE study, Grant48 et al. completed a prospective
observational study of 308 subjects from 22 PICUs who were enrolled in the baseline
phase of the study, in order to test the previously developed operational definitions and
estimate rates of occurrence of these sedation-related AEs. The most frequently
occurring AE was inadequate sedation management. Agitation, identified as noted
above, was documented in 30% of subjects and represented 41% of all AE. Clinically
significant iatrogenic withdrawal was documented in 8% of subjects and represented
29% of all AE. The unplanned endotracheal tube extubation rate was 0.82 per 100
ventilator days.48 These results clearly show that critically ill children who require
intubation and mechanical ventilation experience a significant number of adverse events
related to agitation, a key behavior observed in children labeled as difficult-to-sedate.
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Clinical Phenotypes
Clinical phenotypes have been developed as a way to describe patterns of
presentation and response to therapy in an effort to provide the most appropriate and
effective care in a timely way. Defining sedation-related clinical phenotypes in critically ill
children would facilitate sorting these patients into subgroups, allowing specific therapies
to be targeted to particular subgroups based on that subgroup’s unique clinical and
physiological characteristics.
In the last 10 years there has been a growing use of clinical phenotyping,
sparked by completion of the Human Genome Project in 2004. Once the entire Human
Genome had been sequenced, researchers began to investigate whether linking clinical
phenotypes to variation in specific genes would facilitate identification of subgroups of
patients with a particular disease process who would benefit most from tailored therapies
or “precision medicine”.
Precision medicine has become a priority for the nation. In his 2015 State of the
Union address President Obama announced a $215 million dollar line item for the
Precision Medicine Initiative.93 As defined by the Precision Medicine Working Group94
“Precision medicine is an approach to disease treatment and prevention that seeks to
maximize effectiveness by taking into account individual variability in genes,
environment, and lifestyle.” The goal of this initiative is to “pioneer a new model of
patient-powered research that promises to accelerate biomedical discoveries and
provide clinicians with new tools, knowledge, and therapies to select which treatments
will work best for which patients.” Stated simply, the goal of precision medicine is to
“deliver the right treatment to the right patient at the right time.”93
Having phenotype information would facilitate more effective ways to treat
disease.95 A defined clinical phenotype facilitates the classification of a patient into a
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clearly identified sub-group of a specific clinical state that responds to specific therapies
in a typical fashion for the sub-group. The utility of clinical phenotypes is that
identification of these homogeneous subgroups of patients facilitates research specific to
the phenotypic group to determine risk factors or unique response to particular therapies
within the group.96 This knowledge then guides targeted therapy, with the goal that
members of the clinical phenotype receive the most appropriate and effective care in a
timely way.
Descriptions of clinical phenotypes can be found in the biomedical literature
beginning in the 1960s. Usually associated with specific disease entities, and therefore
described in a clinical setting, clinical phenotypes describe patterns identified in a
patient’s presentation and response to therapies. The clinically observable
characteristics used to identify these patterns may be morphological, physiological, or
biochemical. Clinical phenotypes tend to be subsets of an overarching diagnosis:
chronic obstructive pulmonary disease97 and hypertension98 are examples of diseases
where specific clinical phenotypes have been well described.
The clinical dimensions of clinical phenotypes are most often described in terms
of physical assessment findings. For example, type of wheezing is a key assessment
finding in children with asthma. Depner,99 et al. used wheezing types such as
multitrigger wheeze, unremitting wheeze, recurrent unremitting wheeze, or episodic
wheeze as an important way to characterize pediatric asthma clinical phenotypes. In
sickle cell disease, benign or severely affected clinical phenotype assignment is based
on clinical dimensions that include severity of pain crisis, frequency of hospital
admissions, and complications.100 Knowledge of these assessment findings and the
resulting patterns suggested prompts the care provider to place the patient in a specific
sub-group or category; that is, to assign a clinical phenotype. The usefulness of
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identifying a clinical phenotype is that this categorization results in a meaningful benefit
to the patient. Identifying the clinical phenotypes within a disease identifies groups of
patients who may have an increased need for or respond differently to the typical
therapies used to manage the disease. This guides the clinician in selecting the most
appropriate therapies for that patient.
In order for clinical phenotypes to be useful in clinical practice, three elements
must be present: a clinical condition or disease process, other patients who also have
the clinical phenotype, and clinicians who can recognize the patterns of and identify the
clinical phenotype.101 Having knowledge of the clinical phenotype and the typical
response to therapy can result in earlier treatment, more appropriate drug selection, and
anticipation and avoidance of adverse outcomes. An important aspect of clinical
phenotype is that it must be clearly articulated, so that it is readily applied by the
clinician. If not, a patient could be misclassified, resulting in inappropriate treatment, or
not receiving needed treatment.
Clinical phenotypes are clinical entities, and although the majority of the literature
discusses specific disease processes, clinical phenotypes can also be identified as
subgroups of patients that respond to specific therapies in a typical and consistent
fashion for the subgroup. Knowledge of the sub-group’s response allows the clinician to
predict the trajectory of the clinical course and select appropriate therapies for the
patient that result in beneficial outcomes.
It is known that patients have variable responses to sedation. Clinical
phenotypes can be identified and used to categorize patients who require more or
different sedation to promote best outcomes. Although there is thought to be a genetic
underpinning to sedation response,8 it is the clinical manifestations of the sedation
clinical phenotypes that have immediate impact on the patient, family and clinician.
19

To date, data to allow prospective identification of the difficult-to-sedate child
clinical phenotype do not exist. Identifying this phenotype may allow early identification
of these patients and facilitate development of preventive strategies such as
environmental manipulation and individualized sedation plans which could avoid adverse
effects resulting from inadequate sedation. Latent class analysis, cluster analysis and
classification and regression tree analysis are some of the advanced statistical methods
that have been used to analyze large datasets and identify differentiating factors which
describe different phenotypes within a specific disease process, such as asthma,99,102-104
sepsis105 or chronic obstructive pulmonary disease.101 In the case of intubated and
sedated children these differentiating factors might include demographic, physiological,
developmental, and clinical factors.12-14

Significance
A well articulated clinical phenotype for the difficult-to-sedate child would support
further investigation related to sedation in critically ill pediatric patients by establishing a
definition that could be used consistently by investigators. It also might allow early
identification of the child at risk for under-sedation, which would facilitate more
appropriate, targeted management. As a result the care team could ensure the child
rapidly achieved the targeted sedation goal by selecting the most effective sedation
agents at appropriate doses for that child, while minimizing the risk of adverse events.
Identification of this clinical phenotype will assist in the development of personalized
targeted therapy to minimize the negative effects of excessive sedation medications.
Identification of this clinical phenotype will then inform future work on the identification of
a genetic phenotype for this group of children.

Innovation
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Use of a clinical phenotype to describe response to sedation in a critically ill
pediatric population is a novel way to approach the problem of under-sedation. To date
no research has utilized this approach. Identifying the demographic, physiologic, and
developmental characteristics associated with differing responses to sedation will assist
the care team to provide specific and individualized sedation strategies for critically ill
children. This goal is in keeping with current, innovative research in other areas, which
seeks to identify targeted therapies. Additionally, identifying a group of children who fall
into this clinical phenotype could facilitate an investigation for specific genetic
phenotypes that underlie the clinical phenotype.
This study will take advantage of a unique data set from the Randomized
Evaluation of Sedation Titration for Respiratory Failure (RESTORE) study16
(ClinicalTrials.gov identifier NCT00814099.21), a previously developed data set
containing highly detailed sedation-specific data in critically ill children to identify
characteristics of this clinical phenotype. This approach is also innovative, and
represents an effort to maximize the use of data and respect the contributions of over
2400 children and their families.

Introduction to the Dissertation Format
The proposed dissertation consists of three papers, outlined in Table 3. The first
paper will present the results of a concept analysis using the methodology described by
Walker and Avant15 that includes a systematic review of the pertinent literature resulting
in a clear operational definition and framework of the difficult-to-sedate child clinical
phenotype. The operational definition and framework will be used to construct a
conceptual model, which describes the key variables impacting the degree of sedation
achieved in critically ill children. Paper 2 will describe the process used to establish face
and content validity of the candidate variables identified and seek additional factors to be
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tested through a survey of expert pediatric critical care clinicians. Paper 3 will
investigate a large cohort of children who received sedation while intubated for acute
respiratory failure, building and testing the final model developed to identify subjects who
are members of the difficult-to-sedate child clinical phenotype.

Paper 1
Title: Describing the Difficult-to-Sedate Child: A Concept Analysis
Target Journal: Journal of Pediatric Nursing
Background:
Sedation is routinely used in pediatric patients requiring intubation to facilitate
mechanical ventilation, decrease anxiety and stress, and minimize the likelihood of an
adverse event.23,24,26,27 Sedation targets are identified and sedation scores are utilized to
determine if the desired target has been achieved.23,89 Pediatric sedation scales have
been developed and their psychometric properties have been carefully
examined.(sedation scale references) The particular agents or combinations of agents
used to achieve sedation in the PICU setting have been studied in order to identify the
most effective agents which also have a good safety profile. The specific agents used
have evolved over time as newer and safer agents have become available.23,24,26,27
A finding from these areas of investigation is that not all patients in the PICU
achieve optimal sedation.23,45,49,89 Some of the potential reasons for this fall within
clinicians’ control, such as inappropriate dosing of sedation agents, lack of
environmental controls, uncontrolled pain, or the limitation of parental involvement in the
child’s care. However a portion of this patient population does not achieved the desired
sedation target despite increased doses and the addition of agents. These patients
have been identified as sedation failures or their level of sedation has been described as
under-sedation. Although it is well documented that this subpopulation is routinely seen
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in the clinical setting, there is little known about the risk factors for under-sedation. A
clear mechanism does not exist for identifying which children will be difficult-to-sedate.
Paper 1 describes a systematic literature review, which identifies variables
associated with pediatric sedation in the critical care setting, specifically variables
associated with the difficult-to-sedate child. This information was synthesized using the
concept analysis methodology of Walker and Avant.15 The product of the concept
analysis was a clear operational definition of the difficult-to-sedate child. This
operational definition was used to frame a conceptual model of key factors impacting the
level of sedation achieved in critically ill pediatric patients cared for in the PICU. The
model describes potential variables to test in the development of a clinical phenotype of
the difficult-to-sedate child. Table 4 lists other pertinent operational definitions.
Research Question: What individual, process or system variables are identified in
the literature as associated with the difficult-to-sedate child?
Methods: A literature search of multiple databases, including PubMed, Medline,
EMBASE, ISI Web of Science, Scopus, ProQuest Dissertations, CINAHL, and the
Cochrane Database of Systematic Reviews and Central Register of Controlled Trials
from January 1, 1985 through March 31, 2017 was completed in order to identify
research articles specific to the topic of pediatric sedation in a critical care setting.
Inclusion criteria: The primary focus of the included studies was sedation for
intubation or to facilitate mechanical ventilation in pediatric patients aged 2 weeks post
conceptual age to 18 years cared for in a critical care setting.
Exclusion criteria: Studies primarily focused on dental sedation, procedural
sedation, perioperative sedation or sedation for comfort care were excluded. Studies that
do not report a measure of sedation effectiveness will also be excluded. Abstracts of
papers published in languages other than English were translated.
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Study procedures: A literature search was conducted as described. Additionally,
reference lists of the articles retrieved were reviewed to identify additional studies for
inclusion not identified in the initial search. A flow diagram describing identification of
the final group of studies included in the systematic review is provided in Chapter 2.
Analysis Plan: A table of evidence was utilized to examine the studies reviewed.
Data elements included in the table were: study population, setting, sample size,
sedative agents used, sedation assessment mechanism and definition of under-sedation
used in the study. The Preferred Reporting Items for Systematic Reviews and MetaAnalyses106 checklist was used to rate the quality of each included study. The table of
evidence was used in the analysis of candidate factors for model construction, and a
conceptual model was proposed and is described in Chapter 2.

Paper 2
Title: Appraisal of Face and Content Validity of Variables Associated With the Difficult-toSedate Child in the Pediatric Intensive Care Unit: A Survey of Pediatric Critical Care
Clinicians
Target Journal: Australian Critical Care
Background:
Face and content validity are used to determine if items in a scale or survey are
important and relevant to the topic, clear and understandable. This assessment seeks to
determine if there are adequate and appropriate items to represent the phenomenon or
construct of interest.107 Feedback from experts in the area under study is a method
commonly used to assess face and content validity. A high level of consensus among
the group of experts supports face and content validity.
Paper 2 describes the construction, deployment and results of a survey of
pediatric critical care experts used to validate candidate model variables identified
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through the systematic review and concept analysis. This group was asked to identify
additional variables to consider for the model.
Methods: To establish face and content validity for criteria to be used in a
subsequent study identifying the difficult-to-sedate child clinical phenotype, expert
Pediatric ICU clinicians who are members of a research consortium, the Pediatric Acute
Lung Injury and Sepsis Investigators (PALISI) Network, and an expert study group, the
Society of Critical Care Medicine (SCCM) Pediatric Sedation Study Group, were asked
to complete a questionnaire using the Qualtrics (Provo, Utah) Survey platform. These
groups were chosen because they include active, experienced critical care clinicians
who provide pediatric sedation on a routine basis, and include a variety of providers
including nurses, physicians, respiratory therapists and pharmacists. The SCCM
Pediatric Sedation Study Group is tasked with developing sedation-specific
recommendations for the pediatric critically ill patient. Recommendations on key
elements to include when reporting surveys in publications generated by Duffett,108 et al
were followed in the write up of this study.
Inclusion criteria: All members of each group who are clinicians were included.
Exclusion criteria: Individuals who completed the survey but are not clinicians,
determined by response to a question asking the respondent to identify their role, were
excluded.
Procedures: The Institutional Review Board of the University of Pennsylvania
determined that the study did not require informed consent from participants. A
questionnaire was developed containing questions used to assess face validity of
variables included in the initial model. Two additional questions asked for the
respondent's clinical role and organization. No other demographic information was
collected.
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In order to avoid coercion and maintain confidentiality, the survey was distributed
by a member of each groups’ administrative staff to their email list. Investigators did not
have access to the email list. Participation was voluntary. Submission of a survey was
used as an assumption of consent.
Respondents were asked to answer the questions in relation to a patient’s first
four days of endotracheal intubation, with the assumption that the patient’s pain was
adequately controlled and that sedation medication doses were appropriate. Survey
participants were instructed to score each of the variable items as not (1), somewhat (2),
quite (3), or highly (4) relevant in identifying the difficult-to-sedate clinical phenotype.
Analysis: Descriptive statistics for the two demographic variables, including
frequencies and percentages for nominal/binary variables were reported. All study data
was examined carefully for invalid or outlying values, and distributional assumptions
were assessed where appropriate.
Primary analysis involved calculation of a content validity index,107 used to
identify the factors which respondents felt best identified the difficult-to-sedate child.
Items which scored a content validity index greater than or equal to 0.70 were retained in
the model. The final model created was tested as described in Paper 3.
The primary limitation of survey research is a poor return rate for surveys.109,110 In
order to promote a high rate of return, survey responses were carefully tracked on a
daily basis, and a reminder email was sent by the administrative staff one week after
deployment of the original survey.
The survey site captures all responses in a survey, even if the survey is not
completed, so any data provided in all surveys initiated was captured. However, the
goal is to obtain complete surveys. The survey completion time was short, and the
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survey site provided tools such as a completion bar and formatting for smartphones,
which encouraged participants to complete the survey.
Because the survey will be distributed via email, it is important that the survey
program used be stable and accessible throughout the data collection period. This
survey site has been used extensively throughout the University of Pennsylvania, and
has demonstrated good accessibility, stability and strong data protection and security.

Paper 3
Title: Characteristics of the difficult-to-sedate child phenotype
Target Journal: Pediatric Critical Care Medicine
Background:
The aim of paper 3 is to characterize variability in sedation response within a
cohort of 2,449 subjects enrolled in RESTORE and use data through the first three days
after endotracheal intubation to operationalize and define the difficult-to-sedate child
clinical phenotype.
Typical, over- and under-responders to sedation were compared on
demographic, physiological, developmental and clinical characteristics, as well as
patterns of opioid, benzodiazepine, and other sedative medication administration with
the goal of identifying the characteristics of the difficult-to-sedate child clinical
phenotype.
Methods: A secondary analysis of the RESTORE data set was completed to test
the hypothesis that a phenotype for the difficult-to-sedate child can be described.
The RESTORE (Randomized Evaluation of Sedation Titration fOr Respiratory
failure) study (U01 HL086622 and U01 HL086649) was a cluster randomized clinical trial
designed to test an innovative approach to sedation management in pediatric patients
supported on mechanical ventilation.16 The trial intervention consisted of daily
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assessment of illness trajectory, establishment of an individualized sedation goal and
implementation of a nurse-directed comfort algorithm that guided the sedation/analgesic
management. The sample consisted of 2449 critically ill infants and children supported
on mechanical ventilation from 31 participating pediatric intensive care units (PICUs)
between June 2009 and December 2013. The intervention tested in the trial sought to
improve sedation management in pediatric critical care settings and to reduce the risk of
sedation-associated complications such as failed extubation, iatrogenic withdrawal
syndrome (IWS), and the development of ventilator associated pneumonia (VAP).
Inclusion criteria: All RESTORE subjects who contributed at least two days of
data.
Exclusion criteria: None
Procedures: IRB approval for the parent study was obtained at all study sites.
The parental permission document specifically allowed subsequent use of de-identified
data. Data points extracted from the RESTORE data set were identified based on the
variables included in the final model. A cohort of difficult-to-sedate subjects within the
RESTORE trial data set was generated and then compared to typical response
RESTORE subjects. This was done by developing a subset of patients who had both a
sedation score indicating agitation and opioid and/or benzodiazepine doses above the
standard dose range on the same day, during days 0 through 3, as this is likely the
subset of patients that represent the difficult-to-sedate child clinical phenotype. Several
iterations of models of the difficult-to-sedate child clinical phenotype were considered, as
is standard for the type of analyses planned, in order to best define the phenotype.
Analysis Plan: Using the RESTORE data set, pertinent clinical factors were
identified. Latent Class Analysis111 was employed to characterize the difficult-to-sedate
phenotype in children enrolled in the RESTORE trial. The analysis explored traits such
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as number of inadequate sedation management events, number of sedative medication
classes received, and standardized total daily sedation requirement to maintain target
sedation goal.
Latent Class Analysis (LCA), a hypothesis-free statistical technique, has been
used extensively in clinical phenotype development studies to identify unobserved
(latent) classes by building typologies or clusters based on observable variables within a
data set. We used LCA to analyze the RESTORE dataset, in order to characterize the
difficult-to-sedate child clinical phenotype. LCA has been previously used to identify
phenotypes in acute respiratory distress syndrome,11 pulmonary hypertension,112
COPD,101 and wheezing phenotypes in young children.99,102,103 The model developed
and refined in Papers 1 and 2 was tested in order to develop a final model which used
an appropriate set of demographic and clinical factors as well as agitation-related and
sedation-related characteristics to predict membership in the latent classes. This allowed
characterization of the difficult-to-sedate child clinical phenotype.
We also used Classification and Regression Tree (CART) analysis to identify risk
factors for being difficult-to-sedate. CART methodology has been successfully used to
identify risk in other populations, such as septic pediatric and adult patients,105 and is
useful in uncovering complex interactions when many potential predictor variables and
patterns of relationship exist.113 CART produces cut points and ordering of decision
nodes that clearly discriminate between groups with high and low risk for the response
variable.105,114 We used a randomly selected sample of subjects from the RESTORE
database as the learning dataset, which was used to build the initial classification tree
using RStudio (Foundation For Open Access Statistics, Boston, MA). Cross validation
was used to identify the most accurate and predictive tree. We used the remaining
subjects as the test dataset to validate the initially derived tree. These approaches allow
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characterization of the difficult-to-sedate child who does not respond to standard therapy
and requires a treatment approach that deviates from the norm, as well as associated
risk factors based on demographic and clinical factors.

Limitations, Assumptions, and Design Controls
This study is a secondary analysis of an existing data set, which presents some
potential limitations.91,115-120 A key issue is that the question of interest in the secondary
analysis must fit the data available from the parent study. Operational definitions and the
unit of analysis must be congruent.117 In this case a subset of the parent study data
specifically matches information needed to answer the question of this study. For
example several data points related to sedation levels, as well as daily amounts of
sedation medications and the number of different agents used for sedation was collected
in the parent study. The unit of analysis for this study will be the individual subject,
which matches the parent study.
A potential problem is the inability to identify the difficult-to-sedate child
phenotype. This may occur because the data may be too noisy and a group of
characteristics may not be able to be identified. If this is the case, an alternative strategy
is to calculate a cumulative difficult-to-sedate score for each subject, based on the
previously identified variables and use linear regression and structural equation
modeling to identify which variables predict the difficult-to-sedate child phenotype. A
second potential limitation is that methodological issues may exist related to the parent
study.116-118 The parent study methodology was reviewed by Institutional Review Boards
of the 31 sites which enrolled subjects, as well as the funding organization, the National
Heart, Lung, and Blood Institute of the National Institutes of Health. A related potential
methodological issue is that the parent study was a cluster-randomized trial, with sites
being randomized to the intervention or control arms. The possibility exists that if there
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were significant differences in sedation practices between the control sites, the data
could be skewed. Careful evaluation of data considering treatment arm assignment will
allow identification of any impact of this aspect of the study design.
When using a previously created data set, quality of the data is a potential
limitation, specifically concerns that the data is outdated or inaccurate.116-120 The parent
data set in this case has a high level of quality. A key variable of interest in this study is
sedation scores, obtained by direct assessment of subjects. Multiple procedures were
implemented at each site to ensure accuracy. Medication data is another variable of
interest, and this data was carefully reviewed by monitors over the course of the study to
ensure data accuracy. The parent data set was carefully cleaned to minimize missing
data. If questions arise about the data set, the study investigator will have ready access
to the parent study principal investigators as well as the Data Coordination Center, which
is where all data is held. In terms of concerns that the data is outdated, the parent data
was collected over a five year period, from 2008 to 2014. Data analysis for the present
study is anticipated to occur in 2016-2017. This represents a minimal time lag and
reduces the risk that the data will be outdated.
If the parent data set is not representative of the population of interest, a concern
arises that there will be limited generalizability. Entry criteria for the parent study and
missing data, which may decrease power, are both potential concerns.115-120 As noted,
the parent data base was constructed to minimize missing data and was thoroughly
cleaned. The parent study included children intubated specifically for respiratory
causes, which limits generalizability to the entire PICU population. Although the most
frequent diagnosis associated with intubation in the PICU is respiratory failure, children
are also intubated for reasons such as control of intracranial hypertension, protection of
a surgical incision, or manipulation of cardiopulmonary dynamics. The exclusion of
31

children with “Do not resuscitate” status also limits the ability to generalize to a group
known to present sedation challenges.91 The present study is exploratory and as a
result, information gained in this study will provide direction for subsequent studies
related to these populations.
A final concern related to secondary analysis on an existing data set is that the
parent study may not contain the variables needed to answer the questions posed in the
secondary analysis.116,117 Because the variables of interest will be identified in papers
one and two, this is a possibility, however, extensive data on variables likely to be of
importance was collected in the parent study.
Some assumptions have been made in designing the present study. A key
assumption is that when sedation levels were assessed, pain was controlled. This
assumption is based on the agreement of all participating sites to assess pain using the
same tools and at the same intervals, with minimal assessment intervals of every four
hours. There are several additional assumptions. Factors known to be related to
agitation have been appropriately managed; the environment is appropriate, ventilator
settings are adequate; parent presence and participation in providing comfort to the child
was facilitated; and initial starting doses of sedation medications were appropriate based
on the child’s weight and clinical condition. It is assumed that sedation assessments
were accurate, the sedation level scoring tool was used correctly,122 and that
medications were administered correctly and via an intact intravenous line or enterally,
as appropriate.

Summary
The three papers outlined in this discussion build progressively toward the goal
of answering the primary question explored in this dissertation: Can specific clinical
phenotypes be identified for the critically ill child receiving sedation and mechanical
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ventilation? The systematic review of the literature and concept analysis in paper one
resulted in construction of a model which proposes the key variables impacting the
degree of sedation achieved in critically ill children. Paper 2 describes establishment of
face and content validity for the factors included in the initial model and seeks additional
factors to be tested through a survey of expert pediatric critical care clinicians. Paper 3
describes testing of the refined model using the RESTORE dataset.
The dissertation concludes by providing an in-depth discussion of the overall
findings and significance of the completed work, the implications for research and
practice stemming from the dissertation and how each of the three papers combine to
contribute to the knowledge base of pediatric critical care.
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APPENDIX

Table 1:
Medications Frequently Used for Sedation in the Pediatric Intensive Care Unit
Drug Name
Sedatives
Midazolam
Lorazepam

Therapeutic Class

Dose Range

Notes

Benzodiazepine hypnotic
sedative
Benzodiazepine hypnotic
sedative

0.06-1.2 mg/kg/hr

Max 7
mg/hr
Max 2mg/hr

Opioids
Morphine
Analgesic narcotic
Fentanyl
Analgesic narcotic
Adjunctive Medications
Chloral hydrate
Hypnotic sedative
Clonidine

Sedative α2 agonist

Dexmedetomidine
Diphenhydramine
Ketamine

Sedative α2 agonist
Sedative
Dissociative general
anesthetic

Methadone
Pentobarbital

Narcotic analgesic
Barbiturate, hypnotic
sedative, general
anesthetic
General anesthetic

Propofol

0.025 mg/kg/hr

.01-.06 mg/kg/hr
1-10 mcg/kg/hr
25-75 mg/kg/dose
Oral: 3-6
mcg/kg/day
Transdermal: 0.050.1 mg/d
0.2-2.5 mcg/kg/hr
0.5 – 1 mg/kg
Intermittent: 0.5 – 2
mg/kg
5-20 mcg/kg/min
0.1 mg/kg/dose
1-2 mg/kg/dose

Max 2
gm/dose
Oral daily
dose is
given every
4-6 hours

125-300
mcg/kg/min

< 24 hour
limit on
infusion
Data compiled from references: 7, 22, 23, 25, 26, 52, 53, 55, 58, 61, 65, and 121
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Table 2: Sedation Scoring Tools used in the Pediatric Intensive Care Unit
Tool

Author

Target
Population

Descriptors

Indicators

Scale

COMFORT42

Ambuel
et al

Pediatric ICU
patients
newborn to
adolescent

8 scale
dimensions are
each graded 1-5
and summed to
give a total score

Alertness
Calmness
Respiratory
activity
MAP
HR
Muscle tone
Facial
expression

8, unresponsive
to
40, Hyper-alert
and active

Alertness
Calmness
Respiratory
activity
Muscle tone
Facial
expression
Response to
stimulus or
movement

6, unresponsive
to
30, Hyper-alert
and active

Yes

1, unarousable
to
7, dangerous
agitation
-5,
unresponsive to
+4, combative

Face and
content
validity
only
Adult
populatio
n only

COMFORT-B44 Ista
et al

Mechanically
ventilated
pediatric ICU
patients,
newborn to
adolescent

6 of the
COMFORT
scale
dimensions: HR
and MAP
removed

Pediatric
Sedation
Agitation
Scale45
Ramsay
SedationAgitation
Scale81

Pediatric ICU
patients
newborn to
adolescent
Adult ICU
patients

Level of
responsiveness

Lyden
et al

Sessler
et al

Level of
responsiveness,
behavior

Response to
stimulus or
movement

Reliability
& Validity
Testing
Yes

scores < 18
may be used as
an indicator of
deep sedation

Notes

Global
measure of
comfort/dis
comfort,
including
pain;
includes
physiologic
al
measures
Validity has
also been
evaluated
in young
children
with Down
syndrome47
Adaptation
of an adult
scale
One of the
earliest
sedation
assessmen
t scales
developed
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State
Behavioral
Scale43

Curley
et al

University of
Michigan
Sedation
Scale40

Malviya
et al

MAP= mean arterial pressure

Mechanically
ventilated
pediatric ICU
patients,
6 weeks to 6
years
Pediatric
patients,
newborn to
18 year

Level of
responsiveness

Level of
alertness,
respiratory
activity, ability
to calm

-3 unresponsive
to
+2 agitated

Yes

Level of
responsiveness

Level of
alertness,
response to
stimulus

0, awake to
4, unarousable

Validated
for use
with
procedur
al
sedation

HR= heart rate

Top of
score is
awake and
alert- no
indicators
for
agitation

ICU= intensive care unit
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Table 3: Manuscripts and Specific Aims
Chapter
Chapter 2
The Difficult-to-Sedate Child: A Concept Analysis

Chapter 3
Face and Content Validity of Variables Associated with the
Difficult-to-Sedate Child
in the Pediatric Intensive Care Unit: A Survey of Pediatric
Critical Care Clinicians

Specific Aim

To explore key variables thought to be associated with the
difficult-to-sedate child, propose a conceptual model linking
those variables in critically ill pediatric patients, and validate
or refine the operational definition of the difficult-to-sedate
child proposed in Chapter 1.

To assess both face and content validity of the candidate
variables identified through the systematic review and
incorporated in a preliminary model.

Chapter 4
To build and test a statistical model describing the difficultto-sedate child clinical phenotype.
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Table 4: Operational Definitions
Term

Definition

Sedation Level

Child’s observable response to physical and
environmental stimuli during the administration of
medications intended to decrease the level of
response, measured with a valid and reliable
sedation scoring tool

Sedation Goal

Desired sedation scoring tool value to be achieved
identified by the care team; based on the child’s
illness trajectory and physiologic and psychosocial
ability to tolerate activity, therapies, and
environmental stimulation

Appropriate Sedation Dose

Dose of sedation medication which achieves the
desired level of sedation, without causing
physiologic instability

Optimal Sedation

Child consistently remains within the identified
sedation goal range, without requiring frequent
medication adjustments or additions

Tolerance

Decreasing clinical effect of a drug after prolonged
exposure to it, requiring an increase in dose to
achieve the same effect22
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CHAPTER TWO
The Difficult-to-Sedate Child: A Concept Analysis
Target Journal: Journal of Pediatric Nursing
Abstract
Critically ill children requiring mechanical ventilation receive sedation to promote their
comfort and ensure their safety. Some children do not respond as expected to the usual
sedative medications in typically adequate dosages and are considered “difficult-tosedate”. A review of the literature indicated that the clinical characteristics of these
difficult-to-sedate children have not been well described. The population of mechanically
ventilated children examined was heterogeneous and included children from birth to 18
years of age with a variety of medical and surgical diagnoses. The reported incidence of
undersedation in this population varied widely by cohort studied. Assessment
instruments used to assess level of sedation also varied widely, with no agreement on
the definition of undersedation. This paper provides a concept analysis of the
phenomenon of the difficult-to-sedate child using the methodology of Walker and Avant.
Analysis of the existing literature suggests the following operational definition: the
difficult-to-sedate child is characterized as a mechanically ventilated critically ill child
routinely requiring escalation of sedation doses beginning on day one of ICU care, as
well as the routine administration of adjunctive medications, who reaches doses above
the standard range within the first three days of intubation and remains above the target
sedation goal. Given that these patients are seen in clinical practice, studies using valid
and reliable measures are needed to test this definition in order to develop tailored
treatment strategies.
Keywords
Child, pediatric intensive care, sedation, sedation assessment, concept analysis
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Highlights
•

Children in pediatric ICUs receive sedation to ensure comfort and safety.

•

A subset of children do not respond to sedation as expected.

•

These children remain under-sedated despite receiving typically adequate
sedative doses.

•

This group of “difficult-to-sedate” children have not been well characterized.

•

Effective characterization could lead to more appropriate targeted interventions.
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The Difficult-to-Sedate Child: A Concept Analysis
When a critically ill child remains agitated, despite providing adequate dosages of
sedative agents, clinicians consider them “difficult-to-sedate”. More than 115,000
critically-ill children are admitted to pediatric intensive care units (PICUs) in the United
States due to a critical illness or injury each year.(Agency for Healthcare Research and
Quality, 2014) Sedation is routinely used in these patients to facilitate their comfort, to
help them tolerate invasive therapies, to decrease their anxiety and stress, and to
minimize the likelihood of an adverse event, including unplanned endotracheal
extubation and removal of life-sustaining invasive catheters. 2-5
Although sedation is a key element in pediatric critical care, not all patients in the
PICU are able to be sedated and remain agitated despite receiving adequate dosages of
sedative agents.2,6 Some of the potential reasons for this fall within clinicians’ control,
such as not controlling pain, lack of day-night cycling, or the limitation of parental
involvement in the child’s care. However, a portion of these patients are not able to be
sedated despite increased doses of multiple sedative agents. Multiple terms have been
used to describe these patients, for example, sedation failures or under-sedated
patients. This presents a problem because a clear operational definition of this
phenomenon is necessary for systematic inquiry.
This paper will identify the individual, process and system variables that help
characterize the critically ill difficult-to-sedate child. This information will be synthesized
using the concept analysis methodology of Walker and Avant7 to produce an operational
definition of the difficult-to-sedate child. This definition will then be used to frame a
conceptual model of key factors impacting the level of sedation achieved in critically ill
pediatric patients cared for in the PICU, and ultimately to support further inquiry of the
difficult-to-sedate child.
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Methodology
Walker and Avant’s7 concept analysis framework was developed to provide a
methodical process for defining the core elements of a concept in order to develop an
unambiguous operational definition which can then be tested. The purpose of identifying
a concept (what something is or how it works) is to develop a mechanism to describe
and illuminate a phenomenon of interest, in this case the difficult-to-sedate child. An
important aspect of their method is that after a concept is identified, it must be clarified to
clearly differentiate it from other concepts. Careful examination of the structure and
function of the concept through concept analysis results in concept clarification and
differentiation. This strategy requires examination of a concept’s basic, essential
elements in order to develop a clear, precise operational definition of that concept. The
steps involved in concept analysis as described by Walker and Avant7 are very specific,
and are detailed in Box 1.
The concept of the difficult-to-sedate child is highly pertinent to the clinical setting
and to the clinical work of nurses caring for critically ill children with respiratory failure
who require mechanical ventilation. Benner, Kyriakidis, & Stannard8 describe how
nurses learn to identify patterns of patient responses as they provide care to multiple
patients over time and become skilled at using pattern recognition to respond to evolving
clinical situations. Nurses not only recognize and interpret these patient patterns but
quantify the quality of the response for a particular group or sub-group of patients. This
concept, difficult-to-sedate, describes specific patterns that exist in the presentation and
behavior of a subset of critically ill children while they are receiving nursing care.
Analyzing and clarifying the concept of the difficult-to-sedate child will result in the
development of an operational definition that will facilitate incorporating this variable into
a conceptual model and allow testing of the variable.
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Uses of the Concept and Defining Attributes
Uses of the Concept
Patient sedation is pertinent to several disciplines, including nursing, medicine,
pharmacy, and psychology. In order to identify as many relevant studies as possible,
multiple data bases were searched to identify original research whose focus was
mechanically ventilated critically ill children 2 weeks to 17 years of age receiving
sedation. Table 1 provides details of the databases searched, inclusion and exclusion
criteria and the search terms used. A table of evidence (see Table 2) was constructed to
synthesize study data. Key areas of interest were sedation assessment method,
definition of sedation categories used, incidence of undersedation, and any identified risk
factors for undersedation. The literature review was conducted and reported using the
Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines
(PRISMA).9 Figure 1 provides the PRISMA diagram outlining the search results. The
literature review findings emphasize the need for an analysis of the concept of interest. A
clear operational definition of the difficult-to-sedate child was not identified.
Sedation is widely used to indicate a calm, relaxed, cooperative state brought
about by the administration of a sedative drug. The definitions provided in various
sedation scales used in the studies reviewed demonstrate this well. A COMFORT scale
score between 17 and 26 is frequently used to define optimal sedation. Descriptors in
that range include drowsy, normal muscle tone, calm, occasional slight movement, heart
rate at baseline.10 The COMFORT-B scale is derived from the COMFORT score but
eliminates the physiological parameters of heart rate and blood pressure. A score of 1122 is used to define optimal sedation, and descriptors are similar to the COMFORT
score.11,12 An SBS score of -1, responsive to gentle touch or voice, or 0, awake and able
to calm is generally used to describe optimal sedation. Descriptors in these categories
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include able to calm with comforting touch or voice when stimulus removed, able to pay
attention but drifts off after stimulation, occasional movement of limbs or shifting of
position. Descriptors in the inadequate sedation range for the SBS include the following:
does not consistently calm/unable to console, or unsafe (biting endotracheal tube,
pulling at catheters, cannot be left alone).13 The COMFORT and COMFORT-B
descriptors include hyperalert, panicky, fights ventilator, coughing, choking, screaming,
and facial muscles contorted, grimacing.10,11 This depicts a clear and unambiguous
difference in the state of optimal versus inadequate sedation.
It is also important to define difficult. The studies reviewed here describe
treatment failure and persistent under-sedation, and the multiple strategies such as
adjunctive medications used in an attempt to achieve optimal sedation when describing
children who are difficult-to-sedate. Other PICU specific sedation literature supports this
definition. The terms “refractory agitation” and “therapy-resistant” are used by van der
Zwaan et al.14 to describe the use of an alternative drug for sedation in a series of four
critically ill PICU patients who did not achieve an acceptable level of sedation with usual
management.
No studies were undertaken with the purpose of describing the incidence of
undersedation in critically ill children or the difficult-to-sedate child. The purpose of the
studies identified can be grouped into four categories. These include evaluation of
sedation drug effectiveness, psychometric testing of sedation assessment instruments,
comparison of sedation assessment instruments with a more objective measure, and
evaluation of a sedation protocol. Multiple instruments were used to assess sedation.
The definition of over, under and optimal sedation varied between studies, even when
the same instrument was used. Incidence of undersedation was reported in a variety of
ways and as a result, there was a wide range of reported incidence of undersedation.
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Sedation failure was a frequently used term to describe children who were
difficult-to-sedate, although the definition of the term was not consistent across studies.
Many studies used reaching the maximum infusion dose of the sedation drug with
sedation scores remaining in the undersedated range to define difficult-to-sedate
children.15-17 Studies of sedation assessment instruments generally used being unable to
maintain sedation scores in the desired range as the definition of undersedation.10-13 One
study identified inadequate sedation management, defined as two or more hours with an
SBS score of +1 or +2 despite the provision of appropriate sedation, as an adverse
event.18
Two demographic characteristics were identified as possibly typical of difficult-tosedate children; Trisomy 2111 and young age.19,20 In general, little information was
provided about study subjects who were difficult-to-sedate, limiting the ability to identify
characteristics these subjects have in common.
Defining Attributes of the Difficult-to-Sedate Child
Systematic analysis supports considering the following attributes in a description
of the difficult-to-sedate child. The child is critically ill and receiving sedation while
mechanically ventilated. The child is assessed as undersedated despite reaching the
maximum rate of sedative infusion as outlined in commonly accepted practice
guidelines. The child requires adjunctive medications due to ongoing sedation scores in
the undersedated range. The child is aged birth to 3 years. The child has a diagnosis of
Trisomy 21.
The attribute of young age is well supported in the pharmacology literature.
Pharmacokinetics and pharmacodynamics studies carried out in both healthy and
critically ill pediatric patients show a difference in drug clearance, elimination, and
response between neonates, infants, children and adolescents.21 Factors related to
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changes in growth and maturation of organs and physiologic systems drive these
differences.22,23 de Gast-Bakker et al.24 identified that one to four year old children
required higher midazolam doses per kilogram of body weight than other age groups.
Morphine, fentanyl and pentobarbital are other sedation medications affected by both
age and weight. Critical illness compounds these developmentally driven effects.25 Ince
et al.26 found decreased midazolam clearance in critically ill children compared with
pediatric oncology patients receiving procedural sedation and healthy infants receiving
postoperative sedation.
Trisomy 21 as an attribute has limited support. While de Wildt et al.17 describe
treatment failure in a child with the diagnosis of Down syndrome, Valkenburg et al.27
found similar COMFORT-B cutoff values when assessing pain and distress in children
with and without Down syndrome.
Ista et al.11 also noted that sedation scores trended higher in the day, so unit
specific practices related to managing the environment, such as quiet time, may also be
a variable to include.
Related or Similar but Non-equivalent Concepts
There are several concepts related or similar to the difficult-to-sedate child.
Optimal sedation describes a calm, cooperative child who tolerates the PICU
environment. An oversedated child is minimally responsive to the PICU environment
and may require decreased drug doses. Procedural sedation involves a single sedation
episode in order to complete a procedure. In this case, the goal is usually that the child
receive short-term sedation which is stopped shortly before or at the time the procedure
is completed, and the child returns to baseline status. Many children who receive
procedural sedation do not require intubation and mechanical ventilation.
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Agitation is another related concept. Agitation is usually described in terms of
physical activity and makes up one element of the sedation assessment scales used
here, but agitation alone does not define difficult-to-sedate. Tolerance, or the
requirement for increasing drug doses over time is also a related but non-equivalent
concept. Tolerance develops over time, where the difficult-to-sedate child generally
requires steady increases in sedation doses beginning shortly after intubation and the
initiation of mechanical ventilation. A study by da Silva et al.28 identified that children
who developed tolerance reached double their initial sedation medication dose between
days three and five. Anand et al.29, in a multicenter clinical trial which enrolled 419
children found that 16% of the study population received double the initial opioid dose by
day 7, which differs from the trajectory described for children who remained difficult-tosedate in the reviewed studies.
Another related concept is iatrogenic withdrawal syndrome (IWS). Agitation and
restlessness are often seen in children experiencing IWS, and are also some of the
descriptors of the difficult-to-sedate child. A systematic review by Best, Boullata, and
Curley30 described IWS and identified longer duration of therapy and higher cumulative
dose of benzodiazepines and opioids as the two strongest risk factors for the
development of IWS. Children we characterize as difficult-to-sedate receive multiple
medications at increased doses, putting them at risk for IWS, but IWS develops later in
the child’s clinical course and the child typically has neurological and gastrointestinal
symptoms in additional to agitation or restlessness.
Delirium is also a related concept. The European Society of Paediatric and
Neonatal Intensive Care (ESPNIC) position statement on assessment of pain, sedation,
withdrawal and delirium in critically ill infants and children31 clearly demonstrates the
overlap in presenting signs and symptoms when comparing delirium and the difficult-to62

sedate child. Delirium is a brain dysfunction, manifested as acute onset of disturbances
in cognition and consciousness with inattention, altered cognition, and a fluctuating
course, which develops over time but has an acute onset.31-33 Opioids and
benzodiazepines have been identified as an underlying cause of delirium in pediatric
patients. Three types of delirium have been described in critically ill pediatric patients.
Hypoactive delirium is the most common presentation and signs and symptoms are the
opposite of the difficult-to-sedate child. The child is withdrawn, apathetic, and unable to
focus or interact. Hyperactive delirium presents as agitation, an inability to focus, and
inconsolability. The child has altered perception, which may include hallucinations. The
severity of the hyperactive behavior fluctuates throughout the day, with the child often
becoming more agitated in the evening or night.31-33 In contrast, the difficult to sedate
child is consistently agitated, often hyper alert, with short periods of calm occurring
directly after the administration of additional sedatives, and appears to respond to the
environment appropriately. The third type of delirium is identified as mixed, with the child
fluctuating between a hypoactive and a hyperactive state. As opposed to the difficult-tosedate child, this fluctuation is not necessarily related to the administration of sedatives,
and periods of hypoactivity are variable in length.32 The child who is difficult-to-sedate
consistently has agitated behavior without altered mental status; actions are purposeful
and goal directed, such as removal of the endotracheal tube. In a large multi-center
point prevalence study of pediatric delirium, Traube et al34 reported that children who
were in the ICU 3 or more days were more likely to have a diagnosis of delirium. The
difficult-to-sedate child generally would require escalating treatment in their first day of
care.
Sample Cases
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The model case presented here is a composite of many patients described in the
clinical setting. Susie is an eighteen-month old who has had a developmentally
appropriate course. She was admitted to the PICU last night with pneumonia. She was
initially managed on non-invasive ventilation but her respiratory failure progressed and
she required intubation and mechanical ventilation. Her respiratory status has stabilized.
The unit has in place a nurse-managed sedation protocol, which includes sedation
assessment using the SBS at least every four hours and with any sedation infusion
adjustments, which the nurse implements following the protocol. Susie was started on
continuous infusions of midazolam and morphine after receiving bolus doses at the time
of intubation. Over the last 8 hours she has required five increases in her midazolam
infusion and multiple bolus doses, as her SBS score is consistently +1 (restless and
difficult to calm) to +2 (agitated). Susie’s mother is at the bedside and is providing
appropriate soothing strategies. Susie’s nurse has determined that Susie is not in pain,
that her intravenous line is patent, and that she is not hypoxic. After Susie sits bolt
upright in bed which threatens the security of her endotracheal tube, the nurse calls the
nurse practitioner to the bedside to request an evaluation of Susie’s sedation plan.
Pentobarbital is ordered and given as an adjunctive medication. Susie doses off, and
her nurse and mother breathe a sigh of relief. Thirty minutes later Susie is again awake
and agitated, with an SBS score of +1. In this model case, Susie demonstrates the
attributes identified through the concept analysis. On her first day of intubation, Susie’s
medications are rapidly escalated per the sedation protocol, but she remains agitated.
She requires adjunctive medications, but does not achieve optimal sedation for more
than a short time. There are no underlying causes such as pain or hypoxia that would
explain her agitation. Her mother is present at the bedside and providing appropriate
support. She does not reach a state of optimal sedation.
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A borderline case contains some but not all of the required attributes. Sam is a 6
month old admitted from the emergency department to the PICU intubated and
mechanically ventilated with respiratory failure due to respiratory syncytial virus.
Morphine and midazolam infusions are begun per protocol. Sam’s SBS score fluctuates
between 0 (awake and able to calm) and +1, and he requires bolus doses of midazolam
about every 2 hours. He has required one increase in his midazolam infusion in the
course of a 12 hour shift. His mother is at the bedside providing appropriate support. In
this case, Sam has required a single increase of his infusion, but does not require
adjunctive medications, and reaches the desired level of sedation for a significant portion
of the time.
A related case contains some of the attributes of the identified concept. John is a
three year old, admitted to the PICU intubated and mechanically ventilated after
abdominal surgery. He is begun on the sedation protocol, and over the course of a 12
hour shift, his nurse increases his morphine infusion twice, his midazolam infusion once,
and he receives a total of 9 bolus doses. John’s SBS score is 0 to -1 (responsive to
gentle touch or voice), but his pain score is consistently 4 or 5/10, until 20 minutes after
the second increase in his morphine infusion, when it decreases to 2/10. In this case,
increases in the medication infusions were required, as well as additional bolus doses,
but John did not have an elevated SBS score. Once his pain was well controlled, he did
not require further increases. He also did not require any adjunctive medications.
Contrary cases are cases that clearly do not represent the concept described,
and in fact are the opposite of model cases. For example, Justine is a five year old
admitted to the PICU with respiratory failure, intubated after failing a trial of hi-flow nasal
cannula. She is begun on the sedation protocol, and her first SBS score assessment is 3 (unresponsive). Her nurse attributes this to the medications she received to facilitate
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intubation. After 4 hours Justine is again assessed, and her SBS score remains -3. Per
protocol, the nurse decreases Justine’s midazolam infusion, but her SBS score remains
-3 to -2 (responsive to noxious stimuli). Her sedation infusion continues to be decreased
per protocol until Justine’s SBS score reaches -1. Justine’s response to the sedation
medication differed in that she required a much smaller dose than usual, and in fact was
oversedated for a period of time. As her infusion dose was decreased she became less
sedated, but remained in the optimal sedation range.
These clinical cases all involve PICU patients receiving sedation to facilitate
mechanical ventilation, but demonstrate each patient’s individual response to sedation.
Susie, John, and Justine represent different patterns of response to sedation. Justine is
oversedated in response to the typical sedation dose, John achieves optimal sedation,
and Susie represents the difficult-to-sedate child.
Identify Antecedents and Consequences
Antecedents are events that must take place prior to the occurrence of the
concept.7 A significant antecedent for the difficult-to-sedate child is that the child requires
sedation for ICU therapies. Others include a care team knowledgeable about standard
sedation dosing and administration, a valid and reliable instrument for measuring level of
sedation, and an identified sedation score goal for the patient. Another is that no other
reason exists which could cause the child to remain agitated, for instance hypoxia,
untreated pain, technology issues such as a malfunctioning IV pump or catheter, or
incorrectly mixed sedation medication solutions. Unit culture may be another antecedent
of this concept. It is possible that local practices may influence identification of children
as difficult-to-sedate, as some subjectivity occurs with the use of assessment
instruments. Over time, there may be practice drift, and more children may be scored as
undersedated. For example, a unit with a high rate of unplanned extubation may
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interpret any activity as concerning, score children as undersedated and as a result
increase medication doses, or more readily utilize adjunctive medications.
As described by Walker and Avant7, consequences are the outcomes of a
concept. In the case of the difficult-to-sedate child, having knowledge of this pattern of
response to sedation therapy might result in earlier treatment, more appropriate drug
selection, and anticipation and avoidance of adverse outcomes. It would also guide
interactions and communication with the family, to help them understand how
management will be tailored to their child based on the child’s response to therapy.
There is also the possibility of negative consequences. If the clinician inaccurately
identifies the child as difficult-to-sedate, the therapy and care provided may be
excessive, or an underlying condition such as hypoxia may not be identified and treated.
This would result in harm the patient.
Empirical Referents
The final step in the concept analysis is defining empirical referents. Walker and
Avant7 define empirical referents as ways in which the concept is measured or
determined. There are several empirical referents of the difficult to sedate child, and not
all of them must be present at any one time. Sedation scores are a primary empirical
referent. Empirical referents include other clinical signs and symptoms, for example
agitation, response to medication, ventilator dysynchrony or inability to achieve the
target sedation goal despite multiple medication adjustments. Patient characteristics
such as age, gender, weight, strength or mobility are also empirical referents.
Physiologic measures include heart rate and blood pressure, sweating, and response to
usual therapies administered.
Operational Definition
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As a result of the iterative process of analyzing the concept of the difficult-tosedate child this operational definition is provided: the difficult-to-sedate child is
characterized by a mechanically ventilated critically ill child routinely requiring escalation
of sedation doses beginning on day one of ICU care, as well as the routine
administration of adjunctive medications who reaches doses above the standard range
within the first three days of intubation and remains above the target sedation goal. It is
likely that this child is young, and possible that the child has a diagnosis of Down
syndrome. This classification facilitates prediction of trajectory, selection of appropriate
therapies on the part of the provider and improved and clinically meaningful outcomes.
Conceptual Model
Themes identified through the literature review point to three types of factors to
consider in constructing a conceptual model of sedation in the critically ill child.
Demographic and medical history factors include age, severity of illness, and coexisting
diagnoses, such as Down syndrome. Weight or body-mass index, unique genetic code
and the child’s physiology may also be important as these impact drug distribution and
clearance. Factors specific to the environment where care is provided may include unit
practices related to parent presence and maintaining normal day/night cycles, as well as
staffing ratios, interrater reliability for sedation assessment instruments used and the
degree of adherence to sedation protocols. Factors specific to the process of providing
and managing sedation include the sedation assessment instrument selected, use of a
sedation protocol, whether the protocol is nurse-driven, standard and adjunctive
medications used and local standards for maximum allowable dose. Figure 2 provides a
depiction of the model developed.
Discussion
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The existing literature does not present a clear operational definition of the
critically ill, difficult-to-sedate child requiring sedation. The current literature identifies the
use of multiple sedation assessment instruments, several of which have not been tested
for validity or reliability. Difficult-to-sedate is not consistently defined in the studies
reviewed, and the incidence of difficult-to-sedate is reported in a variety of ways. Few
characteristics of the difficult-to-sedate groups were reported. It is evident from the
literature that difficult-to-sedate children are routinely seen in clinical practice, and
require a different approach to sedation.
The benefit of identifying difficult-to-sedate children early in their treatment
course is clear. The clinical manifestations seen in this group of children have an
immediate impact on the patient, family and clinician. Sustained periods of agitation
impact the child’s psychologic and physiologic health. Parents may feel less confident in
the care team if they perceive the team is unable to manage their child’s clinical state.
The goal of identifying children who have the difficult-to-sedate pattern of
response to sedation is also very much in keeping with the National Precision Medicine
initiative. The goal of this initiative is to identify which treatments will work best for which
patients. Stated simply, the goal of precision medicine is to deliver the right treatment to
the right patient at the right time to facilitate more appropriate, targeted management.35
Clearly describing the population of children who are difficult-to-sedate could facilitate
rapidly achieving the targeted sedation goal in this group, by identifying that these
children need a different sedation approach than the “typical” child and require different
sedation agents at different doses. This could also minimize the risk of adverse events
and the negative effects of excessive sedation medications.
Future Directions
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The model developed identifies several variables appropriate to investigate in
validating the operational definition of the difficult-to-sedate child. The validated
definition can then be used in further studies with the goal of early patient identification,
early intervention, and the development of effective treatment strategies, both
pharmacologic and non-pharmacologic. There is also the opportunity to test the
economic impact of early identification of the difficult-to sedate child population, as
caring for these children increases the need for nursing resources, there are increased
drug costs, and the current management strategies may increase both PICU and
hospital length of stay.
The difficult-to-sedate child describes a patient population that presents
challenges to the care team, and increases the stress of the child and family at an
already stressful time. Studies are needed to validate the characteristics of the difficultto-sedate child in order to describe this group of children who consistently demonstrate a
particular pattern of response to sedation. This would support the development of
tailored treatment strategies and more effective management. Identifying the
demographic, physiologic and developmental characteristics associated with differing
responses to sedation will assist the care team to provide specific and individualized
sedation strategies for critically ill children. This goal is in keeping with current,
innovative research in other areas, which seeks to identify targeted therapies.
The next step in moving this work forward will be a survey of PICU clinicians in
order to establish face and content validity of the factors outlined in the model as
characteristic of the difficult-to-sedate child. Those characteristics that are identified as
valid can then be solidify the proposed operational definition of the difficult-to-sedate
child clinical phenotype. The proposed clinical phenotype can then be tested
prospectively and if found to be valid can then be used as the basis for further
70

investigation to establish additional characteristics this group of difficult-to-sedate
children have in common. Once the clinical phenotype is well described, a further step
would be to search for an associated genotype. Clarification of the concept of the
difficult-to-sedate child identifies that different sedation strategies are needed for
different subgroups of critically ill pediatric patients. PICU nurses, as the members of
the care team who spend the most time with these children, have a vested interest in
understanding this patient population and play a key role in moving this research
forward.
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Table 1: Search Strategy
•

PubMed, EMBASE, Web of Science, SCOPUS, CINAHL, and the Cochrane
Database of Systematic Reviews and Central Register of Controlled Trials
were searched.

•

Inclusion criteria: original research on the topic of sedation to facilitate
intubation and mechanical ventilation in pediatric critical care patients 2 weeks
to 17 years of age from January 1, 1985 through March 31, 2017.

•

Additional inclusion criteria:
o

level of sedation was measured with a scale

o

the study included a definition of under, over, and optimal sedation.

o

Papers published in languages other than English which had an
abstract translated into English were screened, and two articles were
subsequently translated for review.

•

Exclusion criteria: studies focused on dental sedation, procedural sedation,
perioperative sedation, sedation for comfort care, pain, studies in the neonatal
intensive care population, and studies including non-intubated patients.

•

Reference lists of articles included in the review were examined to identify
additional studies for inclusion.

•

A research librarian was consulted to ensure an effective search strategy.

Search terms:
1. ventilator* OR ventilation* OR respirator* OR Respiration, artificial OR artificial
respiration OR Intubation OR endotracheal OR mechanically ventilate OR
ventil* OR artificial ventilation
AND
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2. infant* OR neonate* OR newborn* OR pediatric OR paediatric OR child OR
children OR teen* OR adolescent* OR youth OR juvenile
AND
3. sedation quality* OR quality of sedation OR sedation level OR level of sedation
AND
4. pediatric critical care OR paediatric critical care OR paediatric intensive care
OR pediatric intensive care OR PICU
AND
5. measur* OR evaluat* OR tool* OR battery OR instrument* OR inventor* OR
checklist OR indicator OR score* OR scoring OR questionnaire OR series OR
scale* OR protocol* OR appraisal OR assessment OR behavior* OR guideline
OR algorithm OR sedation scale OR sedation assess* OR sedation protocol
AND
6. nurs* OR nursing assess* OR nursing assessment
AND
7. pharmacodynamic OR sedat* OR midazolam OR lorazepam OR diazepam OR
benzodiazepine* OR fentanyl OR remifentanil OR morphine* OR ketamine OR
dexmedetomidine OR clonidine OR pentobarbital OR opioid* OR propofol OR
hypnotic OR depressant OR narcotic* OR *drug therapy OR drug utilization

81

Table 2: Studies Evaluated
Study

Site

Design/Testing

Sample Size

Age

Sedation
Assessment Scale
COMFORT-B

Under, over, optimal
Sedation Definition
Under >17
Optimal 11-17
Over <11

Undersedation
Incidence (%)
4% pre-protocol
8% post-protocol

Dreyfus et al
(2017)36

PICU
France

Prospective
observational

n= 200

0 to 18
years

Gaillard-Le
roux et al
(2017)37

PICU
France

Sedation
protocol
Prospective
observational

n= 194

28 days to
18 years

COMFORT-B

Not reported

n = 37

2 to 9
years

COMFORT

Target 1
Under >17
Optimal 11-17
Over <11
Target 2
Under >11
Optimal 8-11
Over <8
Under >26
Optimal 17-26
Over <17

Beytut et al
(2016)38

PICU
Turkey

n = 112

3 to 14
months

COMFORT-B

Under >22
Optimal 11-22
Over <11

257 episodes of
agitation reported

n= 2449

2 weeks
to 17
years

SBS

Under +1/+2
Optimal -1/0
Over -3/-2

547 events SBS +1/+2 for
2 hours despite
treatment

n = 172

0 to 18
years

COMFORT-B
NISS

COMFORT-B
Under >22
Optimal 12-18
Over <12

COMFORT-B
2168 observations
18%
NISS

Sedation
protocol

da Silva et al
(2016)28

PICU
Brazil

Curley et al
(2015)15

PICUs
US

Neunhoeffer
et al
(2015)39

PICU
Germany

Prospective
observational
Sedation
protocol
Pragmatic RCT
Drug
RCT
Sedation
protocol
Nonrandomized
intervention
trial

Not reported
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Sedation
protocol
Wolf et al
(2014)17

PICUs
UK (10)

RCT

Silva et al
(2013)40

PICU
Brazil

Prospective
observational

n = 125

1 month
to 15
years

COMFORT

n = 11

1 month
to 16
years

COMFORT-B

COMFORT-B
Under >23
Optimal 11-23
Over <11
BIS
Under >80
Optimal 40-79
Over <40

n = 46

Birth to 6
years

COMFORT-B

n = 131

0 to 3
years

COMFORT-B
NISS

COMFORT-B
Under >22
Optimal 11-22
Over <11
BIS
Under >80
Optimal 40-80
Over <40
COMFORT-B
Under >22 OR 11-22
with NISS 1
Optimal 11-22 with
NISS 2
Over <11

Drug

BIS monitor

Amigoni et
al (2012)41

PICU
Italy

Prospective
observational
BIS monitor

Ista et al
(2009)42

PICU
The
Netherlands

Nonrandomized
intervention
trial

NISS
Under 1
Optimal 2
Over 3
Under >26
Optimal 17-26
Over <17

2168 observations
11%
Treatment failure
19/125
(15.2)
Percent of time
undersedated 0-54
COMFORT-B
5.7-11.5%
BIS
14.3%

COMFORT-B
0
BIS
2/46
(4.3)

461/3573 observations
identified as
undersedated (12.9)

83

Sedation
protocol

Darnell et al
(2008)43

PICU
US

RCT

Bustos Bu et
al (2007)44

PICU
Chile

Prospective
observational

Curley et al
(2006)13

PICUs
US

BIS monitor
Prospective
observational

De Wildt et
al (2005)11

Ista et al
(2005)14

PICU
The
Netherlands

PICU
The
Netherlands

n = 72

1 day to
18 years

MMAAS

n=9

9 months
to 14
years

COMFORT

Under >26
Optimal 17-26
Over <17

n = 91

6 weeks
to 6 years

SBS

Under +1/+2
Optimal -1/0
Over -3/-2

8/198
(4)

n = 21

2 days to
17 years

COMFORT

Under >26
Optimal 17-26
Over <17

n = 78

Birth to 18
years

COMFORT-B
NISS

COMFORT-B
Under >22
Optimal 11-22
Over <11
NISS
Under 1
Optimal 2
Over 3

14/242 episodes of
COMFORT score > 26
(5.8)
Note: Could not reach
target sedation in one
patient with Trisomy 21
93/843 (11)

Drug

Sedation Scale
metrics
Prospective
observational
Drug
Prospective
observational
Sedation Scale
metrics

OR 11-22 with NISS 3
NISS
Under 1
Optimal 2
Over 3
Under +3
Optimal +2 to -2
Over -3

Reported mean number
of times subjects
undersedated without a
denominator:
16.7 naloxone group,
14.6 placebo group.
7/90 BIS observations
(7.8)

Note: Daytime scores
consistently higher
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Triltsch et al
(2005)45

PICU
Germany

Prospective
observational

n = 40

3 weeks
to 16
years

COMFORT

COMFORT
Under >26
Optimal 17-26
Over <17

0/40
(0)

n = 75

1 month
to 12
years

COMFORT

BIS
Under >80
Optimal 61-79
Over <61
COMFORT
Under >23
Optimal 13-23
Over <13
Ramsay
Under 1

9.5% of observations

BIS monitor
Twite et al
(2005)5

PICU
US

Prospective
observational

ArenasLopez et al
(2004)10

PICU
UK

BIS monitor
Prospective
observational

n = 14

1 month
to 3 years

COMFORT

Tobias &
Berkenbosch
(2004)46

PICU
US

Drug
RCT
BIS monitor

n = 30

2 months
to 8 years

Ramsay
BIS

Aneja et al
(2003)47

PICU
US

Prospective
observational

n = 48

Ramsay

Under 1
Optimal 2-5
Over 6

Courtman et
al (2003)48

PICU UK

BIS monitor
Prospective
observational

3 months
to 18
years

n = 43

COMFORT
BIS

Alexander et
al (2002)49

PICU
Canada

n = 10

children

COMFORT

PICU
US

Sedation
protocol
Prospective
observational

BIS
Under >80
Optimal 40-80
Over <40
Under >18
Optimal 14-18
Over <14

49/373 observations
(13.1)

BIS monitor
Retrospective
observational

1 month
to 16
years

n = 24

1 month
to 20
years

PICU scale
Tracheal
suctioning scale

Ramsay
Under 1
Optimal 2-4

37/426 observations
(8.7)

Berkenbosch
et al
(2002)50

Drug

110/1022 hours
(10.8)
Treatment failure 3/24
(12.5)
12/30 subjects had at
least one episode of
undersedation
Total number of
episodes not provided
42/458 observations
(9.2)

11/14 episodes
(78.6)
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BIS monitor

Over 5-6

Crain et al
(2002)51

PICU
US

Prospective
observational
BIS monitor

n = 31

1 month
to 5 years

COMFORT

COMFORT
Under >26
Optimal 17-26
Over <17
BIS
Under >80
Optimal 40-80
Over <40

5/62 observations
(8.1%)

Ambrose et
al
(2000)9

PICU
UK

Prospective
observational

n = 30

1 day to 3
years

0 – 10 sedation
scale

2/30 treatment failure
(6.7)

Playfor et al
(2000)52

PICU
UK

Drug
Prospective
observational

Under <2
Optimal 2-7
Over >7

n = 28

Ratcliff scoring
system

1, 2, 4 = acceptable
3, 5 = unsatisfactory

8/81 observations (9.8)

Brunow de
Carvalho et
al (1999)53

PICU
Brazil

Drug
Prospective
observational

1 month
to 16
years

n = 18

2 weeks
to 5 years

COMFORT
Hartwig

COMFORT
2/30
(6.7)
Hartwig
5/30
(16.7)

Parkinson et
al (1997)16

PICU
UK

RCT

n = 43

0 to 15
years

1 – 5 descriptive
scale

COMFORT
Under >26
Optimal 17-26
Over <17
Hartwig
Under >18
Optimal 15-18
Over <15
Under 3, 5
Optimal 2, 4
Over 1

Reed et al
(1996)54

PICU
US

Nonrandomized

n = 28

1 week to
15 years

COMFORT

Sedation Scale
metrics

Drug

Under >26
Optimal 17-26
Over <17

294/799 observations
(36.8)
Treatment Failure 2/43
(4.7)
5/28 subjects
(17.9)
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intervention
trial
Marx et al
(1994)3

PICU
US

Drug
Prospective
observational

n = 85

0 to 8
years

COMFORT

3 weeks
to 19
years
Birth to 19
years

Clinical Sedation
Score

Sedation Scale
metrics

Arnold et al
(1993)55

PICU
US

Rosen &
Rosen
(1991)56

PICU
US

Prospective
observational
Drug
Retrospective
observational
Drug

n= 10
n = 55

Descriptive scale

Five point activity
scale

COMFORT
Under >26
Optimal 17-26
Over <17
Descriptive
Inadequately
sedated = 3
Too sedated = 1
Under 1
Optimal 2-5
Over 6
Under > 3
Optimal 2-3
Over 1

COMFORT
14/110 observations
(12.7)
Descriptive
18/110 observations
(16.4)
21% of total
administration time
<10% of total infusion
time

BIS = bispectral index; COMFORT = Comfort scale; COMFORT-B = COMFORT behavioral scale; MMAAS = Modified Motor Activity Assessment
Scale; NISS = Nurse Interpretation of Sedation Scale; RCT = randomized controlled trial; SBS = State Behavioral Scale; UK = United Kingdom; US =
United States.
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Figure 1: PRISMA Flow Diagram

PRISMA Flow Diagram
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Box 1: Sequential Steps in the Walker & Avant Method of Concept Analysis
1. Identify the concept for analysis; the phenomenon of interest
2. Determine the aims of the analysis, such as clarify the meaning of a concept or
create an operational definition
3. Identify all uses of the concept, including dictionary definitions and use of the
concept in fields other than nursing
4. Review all uses identified to determine the concept’s defining attributes;
characteristics that appear consistently in all sources reviewed
5. Identify related or similar, but non-equivalent concepts
6. Identify a model case; a “real world” case that includes all defining attributes
7. Identify borderline (many but not all defining attributes are present), related (a
few of the defining attributes are present), and contrary (cases that are the
opposite of the described concept)
8. Identify antecedents (events that must occur prior to the concept occurring)
and consequences of the concept
9. Identify empirical referents (how a concept is measured or determined)
Walker, L.O., & Avant, K.C. (2011). Strategies for theory construction in nursing. (5th
ed.). Boston, MA: Prentice Hall.
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Figure 2: Conceptual Model
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Abstract
Background: Clinicians recognize that some critically ill children are difficult-tosedate. It may be possible to identify this unique clinical phenotype for sedation
response using statistical modeling techniques adopted from machine learning.
This requires identification of a finite number of candidate variables to include in
the statistical model.
Objective: To establish face and content validity for 17 candidate variables
identified in the literature as characteristic of the difficult-to-sedate child
phenotype.
Methods: Pediatric critical care clinicians rated the relevance of 17 candidate
variables characterizing the difficult-to-sedate child using a four-point scale
ranging from not (1) to highly relevant (4). Face and content validity of these
variables were assessed by calculating a mean score for each item and
computing an item-level content validity index. Any item with a mean score >1
was rated as having adequate face validity. An item-level content validity index
≥0.70 indicated good to excellent content validity.
Setting and Participants: Web-based survey emailed to members of the Pediatric
Acute Lung Injury & Sepsis Investigators Network or the Society of Critical Care
Medicine Pediatric Sedation Study Group.
Results: Of 411 possible respondents, 121 useable surveys were returned for a
response rate of 29%. All items had a mean score >1, indicating adequate face
validity. Ten of 17 items scored an item-level content validity index ≥0.70. The
highest scoring items were requiring three or more sedation classes
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simultaneously, daily modal sedation score indicating agitation, sedation score
indicating agitation for 2 consecutive hours, receiving sedatives at a dose >90th
percentile of the usual starting dose and receiving intermittent paralytic doses for
sedation.
Conclusions: Computation of an item-level content validity index validated
candidate variables to include in statistical modeling of the difficult-to-sedate
phenotype. The results indicate consensus among pediatric critical care
clinicians that the majority of candidate variables identified are characteristic of
the difficult-to-sedate child.
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Introduction
Each year, more than 115,000 critically ill children receive sedation to help
them tolerate intubation and mechanical ventilation.1 A substantial number of
these children do not respond as expected to appropriately dosed sedation and
remain agitated for some period of time, leading to iatrogenic injury and
increased stress.2-5 These children, who remain agitated despite receiving usual
doses of sedation, or who eventually reach their target sedation goal but require
much larger amounts of sedative drugs, are considered by the clinical team to be
difficult-to-sedate. Little is known about the reasons contributing to this
phenomenon in these children, preventing early identification of the child who will
be difficult-to-sedate. The child is often identified as difficult-to-sedate at the time
care providers are actively administering sedative drugs, resulting in a delay in
the attainment of therapeutic concentrations and the desired clinical effect. This
experience causes excessive and potentially avoidable burden on the child and
family, and increases the chances that the child’s safety has been compromised,
and injury may have occurred. Developing a mechanism to identify the difficultto-sedate child could allow for early identification, and prepare the care provider
with a priori knowledge that the child may require more than the typical sedation
needs. However, the first step towards the goal of early identification is
consensus on the characteristics defining the difficult-to-sedate child.
Background
Many factors hamper identification of the difficult-to-sedate child.
Sedation in the pediatric intensive care unit (PICU) is a complex phenomenon,
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impacted by multiple variables. Easily implemented, valid and reliable
instruments that describe sedation levels in children have only become available
and widely used in the last decade.6,7 Patients cared for in the PICU vary widely
in age and encompass enormous physiological and psychosocial differences.
Although well-studied in adults, there are limited data on the metabolism and
elimination of drugs commonly used for sedation in critically ill children.8,9 Organ
maturation and critical illness affect the rate at which sedation medications are
distributed, metabolized and eliminated from the body. The influence of
psychosocial development in response to sedation is not thoroughly described.
There may be a genetic basis for the difficult-to-sedate child, due to
polymorphisms in the genes that encode drug metabolizing enzymes as well as
pertinent receptors.3,10 Finally, each PICU’s individual sedation management plan
dictates how and when sedation is delivered, the specific agents and doses used
to provide sedation, as well as the definition of optimal levels of sedation. These
factors contribute to the challenge of studying sedation in critically ill children.
Defining sedation-related clinical phenotypes in critically ill children would
facilitate better clinical management of these patients while decreasing potential
harm. Specifically, insight into an individual child’s response to sedation would
allow the selection of personalized therapy and potentially contribute to improved
clinical outcomes. Phenotype identification supports treatments geared to the
needs of individual patients by considering each individual’s unique genetic,
biomarker, phenotypic or psychosocial characteristics that distinguish them from
other patients with similar presentations.11 High doses of sedatives and the
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simultaneous use of multiple sedative agents, as typically occurs in the difficultto-sedate child, generally results in adverse effects such as hypotension,
bradycardia, propofol infusion syndrome and iatrogenic withdrawal syndrome.12
Based on recent evidence that prolonged or repeated use of sedative and
anesthetic drugs may negatively affect the developing brain by causing brain cell
death, the United States Food and Drug Administration has required a warning
be added to drug labels indicating that brain development in children three and
under may be affected by exposure to these drugs. Included in this group are
some of the most commonly used pediatric sedation drugs including midazolam,
lorazepam, pentobarbital, ketamine and propofol.13 Identifying and providing
targeted sedation strategies most effective for the difficult-to-sedate child could
minimize these effects.
An operational definition of the difficult-to-sedate child clinical phenotype
does not exist. In other populations, advanced statistical methods including
cluster, classification and regression tree, and latent class analysis have been
used to analyze large datasets and create an operational definition of specific
phenotypes within a disease process such as childhood asthma, pediatric sepsis
or acute respiratory distress syndrome.14-16 These statistical methods require
identification of candidate variables likely to be associated with the concept under
investigation. In the case of intubated and sedated children, the difficult-tosedate child clinical phenotype might include a combination of demographic,
physiologic, genetic and developmental factors.17-19
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We sought to create an operational definition of the difficult-to-sedate
clinical phenotype using a large data set from the Randomized Evaluation of
Sedation Titration for Respiratory Failure (RESTORE) study (clinicaltrials.gov
identifier: NCT00814099).20 This data set of 2,449 children with acute respiratory
failure contains hundreds of variables and millions of data points, requiring a
thoughtful approach to identifying candidate variables. Completion of a concept
analysis using the methodology described by Walker and Avant21 was the first
phase in identifying candidate variables from those available in the RESTORE
database.
The next phase in creating our operational definition involved assessing
face and content validity of the candidate variables identified in order to
substantiate their appropriateness and ensure all possible candidate variables
were included. Face and content validity are generally used in instrument
assessment. Face validity assesses whether an instrument seems to measure
what it purports to measure. It assesses the relevance of an item to a construct
in the opinion of experts.22 Content validity is generally used to assess whether
the content of an instrument is inclusive and representative of the domain of
interest; i.e., do the items completely measure the domain.23-25 Polit and Beck25
note that content validity assesses if the items in the tool, when considered as a
group, provide a reasonably complete operational definition of the construct
being measured. Although not intended to be a formal instrument for repeated
use, our survey was constructed to include what we had identified as the
characteristics of the difficult-to-sedate child phenotype. Here we report on the
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face and content validity of candidate variables potentially characteristic of the
difficult-to-sedate phenotype in children based on our survey of expert pediatric
critical care clinicians.
Methods
Design and Data Collection
This study consisted of a web-based survey sent to a purposive sample of
experts, practicing pediatric critical care providers, and is described here using
the Checklist for Reporting Results of Internet E-Surveys (CHERRIES).26 The
survey link was sent via e-mail to all members of the Pediatric Acute Lung Injury
& Sepsis Investigators (PALISI) network and to all members of the Society of
Critical Care Medicine (SCCM) Pediatric Sedation Study Group. These groups
were chosen because members are practicing critical care clinicians with
extensive experience in pediatric critical care and sedation. PALISI members are
clinical researchers from PICUs across North America who collaborate to
conduct multi-center research studies concerning pediatric critical illness, with a
focus on interventions and outcomes.27 Members of the SCCM Pediatric
Sedation Study Group are critical care clinicians from the United States with a
strong interest in pediatric sedation and knowledge of best practices. The
group’s primary charge is to develop guidelines related to pediatric sedation.
The Institutional Review Board of the University of Pennsylvania reviewed the
study and determined it to be exempt from full board review. No personal
information was collected and data was stored on a password-protected drive, to
which only the investigators had access.
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As described above, we developed the list of candidate variables included
in the survey through a literature review and concept analysis. A pediatric critical
care nurse scientist and a pediatric intensivist reviewed an initial draft of the
survey for clarity and completeness. Prior to deployment, the research team
tested the technical functionality of the survey, which used the Qualtrics
(Washington, DC, USA) survey platform. In order to avoid coercion and ensure
anonymity, the PALISI Network Coordinator and SCCM Quality and Guidelines
Specialist forwarded an email containing an introduction, instructions and the
survey link (Appendix A) to their membership. A unique survey link was set up
for each group in order to better describe participants. The survey link was sent
to 389 PALISI members, representing 78 centers on April 6, 2015, with reminder
emails sent one and two weeks later. SCCM task force members (24 members
representing 14 centers) received the initial email on April 22, 2015, with a
reminder sent one week later. Two individuals were members of both groups
and received both sets of emails. The survey was closed to responses on May
8, 2015.
The survey (Appendix B) was a voluntary, self-administered web-based
survey consisting of five screens in total, including an introductory page, a page
displaying questions concerning 17 candidate variables and an “Other (please
list)” free-text question, a respondent demographics page, a page with a single
free-text question, and a final thank you page. The first question in the SCCM
survey asked if the respondent had previously completed the survey. A “yes”
response closed the survey. There were no mandatory items. To encourage
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initial participation, an estimate of the time required for survey completion (“a few
minutes”) was included in the introductory text. To encourage continued
participation once started, a progress bar at the bottom of the screen displayed
the participant’s progress, along with text indicating percent completed. Forward
and back buttons allowed respondents to review and change their answers prior
to survey submission. The survey platform captured all responses entered, even
if the full survey was not completed. To provide context, respondents were
instructed to answer each question in relation to a patient’s first four days of
endotracheal intubation, assuming that the patient’s pain was adequately
controlled and that sedation medication doses were appropriate. Each item
related to the candidate variables was scored as not (1), somewhat (2), quite (3)
or highly (4) relevant in identifying the difficult-to-sedate phenotype.
Data Analysis
Data was downloaded from the survey management site to a passwordprotected drive as an Excel spreadsheet and was analyzed using IBM SPSS
Statistics 24 (IBM, Armonk, NY, USA). Thirteen surveys (11 from PALISI and 2
from SCCM respondents) which were opened but had no data entered were
deleted during data cleaning. All surveys with any data concerning
characteristics of the difficult-to-sedate child were included in the analysis, even if
they were incomplete. Descriptive analysis of the two respondent demographic
questions consisted of calculation of frequencies and percentages. In order to
determine face validity, we calculated the mean score for each item. A mean
score greater than 1 was considered an indicator of acceptable face validity. We
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also calculated an item-level content validity index (I-CVI) for each candidate
variable. The I-CVI is a way to measure interrater agreement of each item in an
instrument, and to identify items that should be retained or deleted from the
instrument. In order to calculate the I-CVI, the number of experts who ranked an
item as quite or highly relevant is divided by the total number of experts.21 A
threshold of 0.70 (at least 70% of respondents rated these items as quite (3) or
highly (4) relevant) was considered an indication of good to excellent content
validity for the item. In order to ensure accuracy and account for missing data, we
used the number of complete responses to the item as the denominator in our
calculations.
Results
One hundred twenty-one clinicians, 113 (95%) physicians, 3 (2%)
advanced practice nurses, 4 (3%) nurse scientists and 1 (<1%) respiratory
therapist responded to the survey sent to 411 individuals for a response rate of
29%. Table 1 provides further detail about response rates and sample
demographics. Of the 89 clinical sites represented by PALISI and SCCM groups,
members from 61 sites (69%) responded, with a mean of 1.6 individuals per site
(range of 1 to 4) completing the survey. Twelve of 17 items related to candidate
variables had a 100% response rate, four had 99%, and one item had a 98%
response rate. Six of 2,040 data points related to the candidate variables were
missing, resulting in a missing data rate of 0.3%. All variables had a mean score
>1, ranging from 1.5, midway between not and slightly relevant, to 3.5, midway
between quite and highly relevant. Table 2 summarizes the I-CVI for each item.
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Ten of seventeen items met the threshold of 0.70. Those items include requiring
three or more sedation classes simultaneously, a daily modal State Behavioral
Scale (SBS) score indicating agitation (SBS +1/+2), an SBS score indicating
agitation for 2 consecutive hours, receiving sedatives at a dose >90th percentile
of the usual starting dose, receiving intermittent paralytic doses for sedation,
suspected delirium, unplanned endotracheal extubation, unplanned removal of
an invasive device, paradoxical response to sedation, and Trisomy 21. At 0.65,
the I-CVI for the item previous sedation exposure did not quite meet the
threshold. The six items which had a low I-CVI were all demographic or
diagnostic characteristics, including not able to verbally communicate, body mass
index >90th percentile, an oncologic diagnosis, moderate or severe cerebral
disability, moderate or severe overall disability, and bronchiolitis.
Responses from the PALISI and SCCM groups were similar. This would
be expected as the members of both groups are practicing clinicians with
experience in pediatric sedation, and the SCCM group was added to increase the
pool of experts. Two items which met the I-CVI threshold in the PALISI group
were just under 0.70 in the SCCM group (both 0.67), paradoxical response to
sedation and sedation doses >90th percentile of the usual starting dose. The
highest-rated item for both groups was requiring three or more sedation classes
simultaneously. The SCCM group ranked suspected delirium and unplanned
endotracheal extubation second and third. The PALISI group ranked daily modal
SBS indicative of agitation and SBS indicative of agitation for two consecutive
hours second and third. The results for the six items which clearly did not meet
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the I-CVI threshold were ranked in the same order by both groups, and each of
these items had an I-CVI <0.50.
Several respondents identified characteristics not listed. Table 3
summarizes the 17 responses provided when the “Other (please list)” option was
selected for the question “Typically has the following
demographics/diagnoses/characteristics”. Young age was listed as a
characteristic by 5 respondents, the remaining characteristics were identified by
single respondents. Table 3 also summarizes the 61 free-text responses listing
other criteria characterizing the difficult-to-sedate child. Twelve respondents
identified age ≤4 years, 8 identified multiple drugs/bolus doses, 5 identified
medical diagnosis, sleep/day-night cycling issues or psychiatric diagnosis, and
anxious parents and rapid change in sedation level were each identified by 4
respondents.
Discussion
There is currently no operational definition of the difficult-to-sedate child in
the pediatric critical care literature. This study assessed face and content validity
of candidate characteristics, derived from a literature review and concept
analysis, to be used in constructing an operational definition of the difficult-tosedate child phenotype. The majority of items met the threshold we set for good
to excellent content validity. The items that did not were all related to
demographic or diagnostic characteristics, and the mean scores for these items
were in the somewhat relevant range. The results support including all candidate
variables evaluated in this survey when developing the model in the next phase
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of our project, as all variables had a mean score >1, indicating adequate face
validity.
Because content validity also considers whether all important elements of
a domain are represented, we were particularly interested in the number of
additional characteristics identified in the free-text responses. A few
characteristics were consistently identified, including young age, sleep or
day/night cycling issues, requiring multiple bolus doses, a psychiatric diagnosis
or parental anxiety. Although not all of these variables were measured in the
RESTORE data set, those that were measured such as age, received medication
to facilitate sleep, received medication to treat delirium, received multiple bolus
doses and medical diagnosis will be added to the list of candidate variables to be
evaluated in the next phase of this project.
In general, there was remarkable consistency between the PALISI and
SCCM responders, despite the small number of respondents and small
population of the SCCM group. Aside from organizational affiliation, there was
minimal missing data, which further supports the consistency of the findings. No
single center was over-represented in the sample, so it is unlikely that responses
were skewed by regional differences such as differing patient populations or local
sedation practices.
As with any survey, several factors may have introduced bias. The survey
was voluntary and participants self-selected, so the results may represent the
viewpoint of clinicians who have a specific point of view related to this topic. The
sample population was drawn from a research network and an expert sedation
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workgroup, and may not be representative of the PICU clinician population in
general. It is also possible that a respondent from either of the groups, who only
received one invitation to complete the survey, may have taken the survey
multiple times or that the two individuals who were members of both groups and
received two invitations may have taken the survey more than once. We
collected minimal respondent demographic data and respondents were not
assigned any type of identifier, so there was no way to identify multiple surveys
from a single individual. Because the survey link was sent via email, it is also
possible that the link may have been provided to an individual not included in the
original sample frame. We attempted to prevent this by including a request that
the survey link not be forwarded in the email sent to the SCCM group, but did not
include this in the PALISI email request. Although no respondent listed an
organization not included in the PALISI or SCCM lists provided by those
organizations, 16% of respondents did not identify their organization. Finally,
95% of the respondents were physicians. Nurses, who are consistently at the
bedside, may have a different perception of the characteristics of the difficult-tosedate child. It would be interesting to solicit the expert opinion of this group of
providers, to see if any additional characteristics are identified.
Conclusions
This survey asked practicing clinicians to assess whether the items identified
through a theoretical concept analysis agreed with their practice experience. The
results of this survey indicate consensus among expert PICU clinicians, primarily
physicians, that the items included in this survey are consistent characteristics
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exhibited by the child who is difficult-to-sedate. They will be used in phase three
of this project to create a statistical model of the difficult-to-sedate child
phenotype. Additional characteristics identified by the expert panel will also be
added to the list of candidate variables to be included in the model. Developing a
mechanism to prospectively identify the difficult-to-sedate child would allow
sedation tailored to the individual child, avoiding the burden placed on the child
and family and decreasing the potential for injury.
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Table 1. Survey Response Details
Total

PALISI

SCCM

n (%)

n (%)

n (%)

61/89 (69)2

59/78 (76)

7/14 (50)

121/411 (29)3

112/389 (29)

9/24 (39)

Attending Physician

115 (95)

106 (95)

9 (100)

Advanced Practice

3 (3)

3 (3)

0

Nurse Scientist

2 (2)

2 (2)

0

Respiratory Therapist

1 (<1)

1 (<1)

0

Center Representation1
Respondents
Role4

Nurse

PALISI, Pediatric Acute Lung Injury & Sepsis Investigators; SCCM, Society for
Critical Care Medicine.
1

Nineteen of 121 respondents (16%) did not indicate organizational affiliation.

2

Due to overlap in organizations represented by PALISI and SCCM members,

total center representation does not equal the sum of PALISI plus SCCM center
representation.
3

Two potential respondents were members of both the PALISI and SCCM

groups, so number of total possible respondents does not equal the sum of
PALISI plus SCCM respondents.
4 Pediatric

ICU Fellow (physician-in-training), Research Assistant, and

Pharmacist were other options but none participated.
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Table 2. Difficult-to-Sedate Criteria: Mean Score and Item-level Content
Validity Index (I-CVI)
Mean
Score

I-CVI
Total

PALISI

SCCM

(n=121)

(n=112) (n=9)

0.93

0.92

1.00

(112)

(103)

(9)

0.82

0.83

0.75

(98)1

(92)2

(6)3

0.79

0.80

0.75

(95)4

(89)

(6)3

0.78

0.78

0.67

(93)4

(87)2

(6)

0.74

0.74

0.78

(90)

(83)

(7)

0.79

0.78

0.89

(95)

(87)

(8)

0.72

0.71

0.89

(87)

(79)

(8)

Total
(n=121)
Sedation Characteristics
Requires 3 or more sedation

3.51

classes simultaneously
Daily modal SBS +1/+2

SBS +1/+2 for 2 consecutive

3.211

3.094

hours
Doses >90th percentile of usual

3.244

starting dose
Intermittent paralytic doses for

3.13

sedation
Sedation-related Events
Suspected delirium

Unplanned endotracheal
extubation

3.15

3.13
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Unplanned removal of an

3.13

invasive device
Paradoxical response to

2.94

sedation

0.71

0.71

0.78

(86)

(79)

(7)

0.70

0.71

0.67

(85)

(79)

(6)

0.71

0.71

0.78

(86)

(79)

(7)

0.65

0.65

0.67

(79)

(73)

(6)

0.43

0.41

0.67

(52)

(46)

(6)

0.24

0.23

0.33

(29)

(26)

(3)

0.23

0.23

0.22

(28)4

(26)2

(2)

0.22

0.22

0.22

(27)

(25)

(2)

0.17

0.16

0.22

(20)

(18)

(2)

0.09

0.10

0

(11)4

(11)2

Demographic/Diagnostic
Characteristics
Trisomy 21

Previous sedation exposure

Not able to verbally

2.98

2.82

2.36

communicate
>90th percentile for BMI

Oncologic diagnosis

Moderate or severe cerebral

1.96

1.914

2.05

disability
Moderate or severe overall

1.93

disability
Bronchiolitis

1.554
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PALISI, Pediatric Acute Lung Injury & Sepsis Investigators; SCCM, Society for
Critical Care Medicine; SBS, State Behavioral Scale; BMI, Body mass index.
Data presented as mean or I-CVI (n of respondents who ranked item as quite or
highly relevant).
1

Total n=119.

2

Total n=111.

3

Total n=8.

4

Total n=120.
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Table 3. Summary of Free-Text Responses
n
“Other” demographics/diagnoses/characteristics that the difficult-to-sedate
child typically has (n=17)
Infant/toddler

5

Lengthy PICU stay

1

Prior history of delirium

1

Airway repair

1

Intoxicated

1

Parents’ expectations

1

>5 days of sedation

1

Autism Spectrum Disorder

1

ECMO/ECLS or CRRT

1

ADHD, anxiety disorder, other psychiatric diagnosis

1

Transplant recipient

1

Multi-organ dysfunction

1

Prematurity

1

Other criteria that characterize the difficult-to-sedate child phenotype (n=61)
Age ≤4 years

12

Multiple drugs/bolus doses

8

Diagnosis

5

Psychiatric diagnosis (e.g., anxiety, autism, ADHD)

5

Sleep/day-night cycling issues

5

Anxious parents

4

Rapid change in sedation level

4

Nursing factors (e.g., experience, nurse/patient ratio)

3

Patient instability limits sedation doses

3

Activity limited by technology or instability

2

Adolescent

2
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History of negative sedation experience

2

Other

6

PICU, pediatric intensive care unit; ECMO, extracorporeal membrane
oxygenation; ECLS, extracorporeal life support; CRRT, continuous renal
replacement therapy; ADHD, attention-deficit/hyperactivity disorder.
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Appendix A. Text of PALISI and SCCM Survey Participation Request Emails
Dear PALISI Network Colleagues,
We are interested in establishing face validity for criteria that will be used in a study
identifying the "difficult to sedate child" phenotype, and would appreciate your expert
opinion. Please take a few minutes to answer 8 questions on our Qualtrics survey
https://upenn.co1.qualtrics.com/XXXXXXXX
Data are encrypted and results will be reported in aggregate. You will have an
opportunity to add a comment at the end of the survey. Thank you for taking the time to
review and respond.

Dear SCCM Pediatric Sedation Study Group Colleagues,
We are interested in establishing face validity for criteria that will be used in a study
identifying the "difficult to sedate child" phenotype, and would appreciate your expert
opinion. Please take a few minutes to answer the following 8 questions. NOTE: If you
have previously taken this survey, distributed to you as a PALISI member, thank you for
your participation. We request that you please answer question 1.
To start the survey please clink on this link: https://upenn.co1.qualtrics.com/XXXX
Please do not forward to your colleagues, as we would like to know your opinion as a
member of the SCCM Task Force.
Data are encrypted and results will be reported in aggregate. You will have an
opportunity to add a comment at the end of the survey. Thank you for taking the time to
review and respond.
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Appendix B. Difficult to Sedate Survey (SCCM Version)
Have you completed this survey as a PALISI member?
 1- Yes
 2- No
NOTE: If “Yes” was selected, the survey skipped all remaining questions and the text
“Thank you for your previous participation” was displayed
The "difficult to sedate child"... (assuming pain is adequately controlled and sedation
medication doses are appropriate)
1. Exhibits a State Behavioral Scale (SBS) score of +1 (restless and difficult to calm) or
+2 (agitated) for two consecutive hours
 1- Not Relevant
 2- Somewhat Relevant
 3- Quite Relevant
 4- Highly Relevant
2. Exhibits a consistent pattern of agitation, demonstrated by a daily modal (most
frequently occurring) SBS score of +1 (restless and difficult to calm) or +2 (agitated)
 1- Not Relevant
 2- Somewhat Relevant
 3- Quite Relevant
 4- Highly Relevant
3. Requires intermittent paralytic doses for sedation management
 1- Not Relevant
 2- Somewhat Relevant
 3- Quite Relevant
 4- Highly Relevant
4. Requires sedation medication doses above the 90th percentile of usual starting
doses (e.g. >0.2 mg/kg/hour for morphine or midazolam)
 1- Not Relevant
 2- Somewhat Relevant
 3- Quite Relevant
 4- Highly Relevant

5.





Requires three or more sedative classes simultaneously to achieve target sedation
1- Not Relevant
2- Somewhat Relevant
3- Quite Relevant
4- Highly Relevant
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6. Experiences sedation-related events that include the following:

1- Not
Relevant

2Somewhat
Relevant

3- Quite
Relevant

4- Highly
Relevant

a) Unplanned
endotracheal
extubation
b) Unplanned removal of
any invasive device









c) Reports of a
paradoxical response
to sedation









d) Suspected of having
delirium









7. Typically has the following demographics/diagnoses/characteristics:

1- Not
Relevant

2- Somewhat
Relevant

3- Quite
Relevant

4- Highly
Relevant

a) >90th percentile for
BMI









b) History of previous
sedative exposure









c) Bronchiolitis









d) Oncologic diagnosis









e) Trisomy 21









f)

Moderate or severe
cerebral disability









g) Moderate or severe
overall disability









h) NOT able to verbally
communicate









i)









Other (please list):

8. Please list any other criteria that you feel characterizes the "difficult to sedate child"
phenotype.

121

9. Please select what best describes your role:
 Attending Physician
 Pediatric ICU Fellow
 Advanced Practice Nurse
 Nurse Scientist
 Respiratory Therapist
 Research Assistant
 Pharmacist
 Other (please list) ____________________
10. Please use the drop down menu to provide the name of your organization. If your
organization is not listed please select "other" (last item in the drop down box).
11. Please provide any closing thoughts that you think may be important to consider with
regard to the "difficult to sedate child" phenotype.
Thank you .... The END!! Please click the Next (>>) button to submit your survey.
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CHAPTER 4

Characteristics of the Difficult-to-sedate Child Clinical Phenotype

Target Journal: Pediatric Critical Care Medicine
Key Words: child; classification and regression tree; critical care; latent class analysis;
phenotypes; sedation;
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Abstract
Objective: To characterize the difficult-to-sedate child clinical phenotype in a cohort of
children intubated and ventilated for acute respiratory failure.
Design: Secondary analysis of prospectively collected data from the Randomized
Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial. Latent
Class Analysis was used to characterize the variability in sedation response through the
first three days after endotracheal intubation to operationalize the difficult-to-sedate child
clinical phenotype. Classification and Regression Tree methodology was used to
develop branching algorithms that identified the characteristics of patients at high-risk for
being difficult-to-sedate.
Setting: Thirty-one PICUs in the U.S.
Patients: 2,449 patients 2 weeks to 17 years old receiving mechanical ventilation for
respiratory failure.
Interventions: None.
Measurements and Main Results: Latent Class Analysis identified a two-class model as
the best fit, with need for adjunctive medications, less organ failure, occurrence of
inadequate sedation events, and normal cognitive state identified as being indicative of
the difficult-to-sedate child latent class. Classification and Regression Tree analysis
produced a tree with 9 nodes. The best fitting model classified 18% of children as likely
to be difficult-to-sedate. The most important sorting variable was need for adjunctive
medications.
Conclusions: Latent Class and Classification and Regression Tree analysis were useful
techniques in identifying likely phenotypic characteristics and clinical risk factors of the
difficult-to-sedate child clinical phenotype. Further prospective study, with the inclusion
of genetic markers, will be useful in validating these findings.
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Patients admitted to the Pediatric Intensive Care Unit (PICU) are a
heterogeneous group on many factors including age, diagnosis, severity of illness, and
medical history. One of the most common therapies children admitted to the PICU
receive is mechanical ventilation. To help them tolerate this invasive therapy, the
majority of children receive sedation, primarily benzodiazepines, but there is great
variability in practice and many classes of sedation medication are routinely used.(1,2,3).
Response to sedation is also heterogeneous. The majority of children respond as
anticipated to appropriately dosed sedation, and are considered to be adequately
sedated.
However, there are children who do not respond as expected. Some children are
over sedated and require less drug than expected. A more challenging group are those
children who are persistently agitated, requiring higher than anticipated doses and
sedation medications from multiple classes.(4) These children may be referred to as
refractory to sedation, sedation failures, or difficult-to-sedate, and are at risk for adverse
events such as unplanned endotracheal tube extubation or removal of other critical
devices such as central venous catheters.(5)
In addition to sedation-related adverse events, the requirement for higher doses
and multiple classes of sedative agents may cause hypotension, bradycardia, drugspecific iatrogeneses such as iatrogenic withdrawal syndrome.(6,7) Also concerning is
recent data that suggests many of most commonly used sedation medications may
negatively impact a young child’s neurocognitive development.(8) Midazolam,
lorazepam, pentobarbital, ketamine and propofol labeling now carry an FDA required
Black Box warning indicating that brain development in children three and under may be
affected by exposure to these drugs.(9)
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Aside from noting that this group of difficult-to-sedate children exists within the
heterogeneous PICU population, there is very limited data describing them. Clinical
phenotypes have been useful in characterizing patients identified as having a
heterogeneous disease process into groups with similar characteristics. This approach
has stimulated research aimed at identifying effective phenotype specific treatment
strategies and has been a successful strategy for patient populations with asthma,
sepsis, and Acute Respiratory Distress Syndrome.(10-12) Two statistical modeling
approaches are frequently used to describe clinical phenotypes. Latent class analysis
(LCA) characterizes subgroups within a particular patient population based on clinical
and biological data. Classification and regression tree analysis (CART) has been used
as a way to predict a particular outcome for a subgroup of patients. The purpose of this
study was to characterize the difficult-to-sedate clinical phenotype in a cohort of children
intubated and ventilated for acute respiratory failure using these two machine learning
techniques.
Materials and Methods
This is a secondary analysis of data from the RESTORE (Randomized
Evaluation of Sedation Titration fOr Respiratory failure; U01 HL086622) study.(18)
RESTORE was a cluster randomized clinical trial designed to test a nurse-implemented
goal-directed approach to sedation management in pediatric patients supported on
mechanical ventilation. The study captured a large amount of prospectively collected
and validated sedation data in a cohort of 2,449 children from 31 participating pediatric
intensive care units. Data collection occurred between June 2009 and December 2013.
Inclusion and exclusion criteria as well as specifics of the protocol are detailed in the
study report.(18) The institutional review board of each participating center approved the
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RESTORE trial. Parental permission was obtained for each enrolled child. When
feasible, assent was also obtained from children 8 years and older.
For this secondary analysis, we examined data from the first three days of study
enrollment only. We chose these days because it is likely the subset of patients that
represent the difficult-to-sedate child clinical phenotype demonstrate this characteristic
early in their treatment course. We also sought to avoid possible confounding effects
related to sedation tolerance or iatrogenic withdrawal syndrome (IWS). We examined
demographic, physiological, developmental and clinical characteristics, as well as
patterns of opioid, benzodiazepine, and other sedative medication administration with
the goal of identifying the characteristics of the difficult-to-sedate child clinical
phenotype. We included all RESTORE subjects who contributed at least two days of
data. There were no exclusion criteria aside from those of the parent study.
We identified an initial list of variables for inclusion in the LCA and CART models
based on a review of the literature and concept analysis.(20) We then surveyed
pediatric critical care clinicians to establish face and content validity of these variables
and to identify other variables to consider for inclusion in the model.(21) Based on the
results of our survey, additional unpublished variables were added to our initial list. The
complete list of variables used in the models is available as Supplement Table 1 but
included baseline demographics, sedation characteristics such as classes of sedation
agents received on study day 0-3, as well as the incidence of sedation related events on
study day 0-3 such as unplanned device removal. The majority of the variables included
in the models were ordinal or categorical, but continuous variables are appropriate for
use in CART analysis, so age, weight, body mass index (BMI), blood urea nitrogen
(BUN), or alanine amino transferase (ALT) were included as continuous variables in the
CART analysis.
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We used an exploratory LCA to analyze the RESTORE data, with the goal of
characterizing the difficult-to-sedate child clinical phenotype. Forty demographic and
clinical variables were included in the initial analysis as possible class defining variables
in the LCA model. For this analysis, we converted all but one variable into a binary
categorical variable. We created a dummy variable for each diagnosis group, resulting in
six diagnoses variables. The Pediatric Risk of Mortality version III (PRISM III-12) score
was converted to a standardized z-score with a mean of 0 and a standard deviation of 1.
The complete data set was randomly divided into a training (n= 1,470) and validation set
(n= 979), with 60% of cases assigned to the training set and 40% to the validation set.
The CART training and validation sets were compared using the t test or chi-squared
test, as appropriate (see Table 1) using IBM SPSS Statistics 24 (IBM, Armonk, NY,
USA). As is appropriate in LCA, clinical outcomes were not included in identifying the
number of latent classes. We used mixture modeling to test a series of 2, 3, 4 and 5
class latent class models using the discovery data set. We used recommended criteria
for model evaluation and selection, including the sample-size adjusted Bayesian
information criterion (ABIC), Aikake information criterion (AIC), the Vuong-Lo-MendellRubin Likelihood Ratio Test (VLMRLRT), and the degree of entropy, used to assess
classification quality.(23, 24) We assessed the parametric Bootstrapped Likelihood Ratio
Test, but it remained low for all models, so is not included here. MPlus, version 7.4
(Muthén & Muthén, UCLA) was used for the LCA.(13,14) MPlus uses full-information
maximum likelihood in latent class model estimation, which allows use of all subjects,
including those with missing data.(25) Each model fitted was evaluated using the criteria
listed above, and the best fitting model which established the number of latent classes
was selected. We then repeated these analyses with the validation data set, to evaluate
model stability across the two groups.
128

We used CART analysis to classify patients into risk categories for being difficultto-sedate. Unlike LCA, CART requires an outcome variable. Using the operational
definition of difficult-to-sedate child clinical phenotype developed from our review of the
literature and survey of expert PICU clinicians, we created a composite difficult-to-sedate
categorical outcome variable, which was positive if the subject had a State Behavioral
Scale (SBS) score of +1/+2 (agitated) and was receiving at least two times the usual
starting dose of an opioid or benzodiazepine continuous infusion on any study day from
day 0-3. CART uses a branching algorithm to classify patients into groups, starting with
2 groups at the first decision node, using a chi-square statistic for each possible
predictor variable. The algorithm then assigns the predictor variable with the highest
calculated logworth statistic as the candidate for splitting the group into two additional
nodes.(26) We used the entire RESTORE dataset to build the classification tree using
the rpart package in RStudio (Foundation For Open Access Statistics, Boston, MA). We
used an unsupervised approach to model development. Cross validation was used to
identify the most accurate and predictive tree. We used the process of pruning to
remove nodes with few observations by setting a complexity parameter, in order to
minimize the cross-validation error rate and identify a workable model. Finally, we ran
the same model by control or intervention group to assess stability of the tree.
Results
Table 1 compares the cohort of difficult-to-sedate subjects, identified as positive
for the outcome variable (n= 473) to those identified as not difficult-to-sedate (n= 1503)
using the t test or chi-squared test, as appropriate. There were significant differences
between the usual care and protocol groups in the parent study on several variables.
Children classified as difficult-to-sedate had a younger age, were less likely to have a
primary diagnosis of asthma, were more likely to be premature or have previous
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exposure to opioids or benzodiazepines and were more likely to have received fentanyl
as their primary opioid. In addition, the difficult-to-sedate children were less likely to
have elevated blood urea nitrogen or alanine aminotransferase levels.
Latent Class Analysis
The training and validation cohorts for the LCA were randomly generated, and
the only statistically significant difference between the groups was that patients in the
training group were more likely to have an elevated ALT. A 2-class model was identified
as the best fit in both the training and validation cohorts, based on both fit statistics and
interpretability of the model. Although the AIC and ABIC continued to decrease in the 3
class model, the VLMRLRT demonstrated a non-significant p-value of 0.76 in the
training and 0.78 in the validation cohort, indicating the smaller, 2 class model was a
better fit. The best log likelihood was replicated in >25% of 1000 iterations. Table 2 lists
the fit statistics for the various models estimated in the LCA.
The children who make up the difficult-to-sedate phenotype identified here have
less overall organ failure. They are less likely to require vasoactive medications, do not
have hepatic or renal failure, have normal ratings for Pediatric Outcome Performance
Category (POPC) and Pediatric Cerebral Performance Category (PCPC), and are not
likely to have an abnormal level of consciousness. This group is more likely to require
neuromuscular blockade to manage agitation, occurrences of an inadequate sedation
management event (SBS +1 or +2 for 2 consecutive hours, not associated with an
extubation attempt), and having a daily SBS high score of +1/+2. Figure one provides a
comparison of the difficult-to-sedate and not difficult-to-sedate groups by phenotype
characteristic. Of note, the probability of class membership differed between the training
and validation groups, with the training cohort having a 43% probability of belonging to
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the difficult-to-sedate class, and the validation cohort having a 19% chance of belonging
to the difficult-to-sedate class.
CART Analysis
The group classified as difficult-to-sedate for the CART analysis were younger,
more likely to receive fentanyl as the primary opioid, received more classes of sedation
medications, be admitted with a diagnosis of pneumonia, and have a history of
prematurity and previous exposure to sedation medications. Patients classified as not
difficult-to-sedate were more likely to be admitted with a diagnosis of asthma or acute
respiratory failure related to sepsis. The final pruned decision tree produced by the
CART analysis of all subjects had nine splitting nodes, with the primary node predicated
on whether or not the child received any adjunctive sedation medications, and is
displayed in Figure 2. Other important splitting nodes were daily modal SBS score,
occurrence of an inadequate sedation management event, presence of an elevated
blood urea nitrogen level, age, weight, and race. Supplement Figure 1 presents variable
importance for the top ten variables.
The prevalence of the difficult-to-sedate child phenotype in this sample was
18.6% (386/2078 subjects), based on the outcome variable developed for the CART
analysis. Due primarily to missing data related to SBS scores, only 821 subjects were
included in the CART analyses. Accuracy to correctly predict a child who was difficult to
sedate was 0.83 (CI, 0.798- 0.851). The sensitivity for the model was low at 21%, with a
high level of false positives and false negatives. The decision tree was highly specific,
correctly identifying 97% of difficult-to-sedate child cases. Table 3 reports the test
characteristics of the CART analysis.
Discussion
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The difficult-to-sedate child in our sample had less organ failure, less
cognitive impairment, higher modal SBS scores and required more than two
agents to manage agitation, including in some situations neuromuscular
blockade. This study was exploratory and identified the clinical characteristics of the
difficult-to-sedate child phenotype proposed in our operational definition and conceptual
model. We used two different machine-learning methodologies in this analysis, to
evaluate if any characteristics were supported in both types of models. Regardless of the
methodology used, sorting points included the requirement for adjunctive
medications, presence of organ failure, particularly renal failure, occurrences of
inadequate sedation events, high daily modal SBS scores and need for vasoactive
medications.
There were some differences noted when comparing the results of each analysis.
The LCA is a descriptive model, which assigns each subject to a single class and for
each indicator variable included in the model provides the probability that any member of
the class will demonstrate that variable. LCA is atheoretical; it does not assess the data
based on an outcome, but rather looks for and reports patterns in the data. The results
of this LCA also provide a more descriptive picture of a child who is not difficult-tosedate being likely to have renal or hepatic failure, an altered level of consciousness, a
history of alterations in cerebral and overall performance, and a requirement for
vasoactive medications. The finding that children with organ failure were more likely to
be in this class is supported by a study which found that midazolam clearance was
decreased in critically ill children.(28) In order to assess the strength of our findings, we
randomly divided our data set, and the findings were very similar across the two groups,
supporting the characteristics identified here for the difficult-to-sedate child clinical
phenotype.
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The CART analysis predicts the likelihood of an outcome, so takes a different
approach to data analysis. The data is also analyzed for patterns, but at each node or
sorting point, there are only two options for assignment. However, many different paths
may lead to the outcome of interest. The tree shown in Figure 2 has three terminal
nodes positive for the difficult-to-sedate outcome and the difficult-to-sedate outcome was
reached through three paths along the decision tree. Important variables in the CART
analysis included primary diagnosis; age, with young age being more predictive of the
outcome; weight, with weight > 8 and < 22 kg being predictive of the outcome; and
requirement for adjunctive sedation medication as an important predictor. The weight
range reported here is typical of the toddler and pre-school age range, which was one of
the characteristics identified in our survey of PICU experts. It is also a finding supported
in the literature. For example, de Gast Bakker et al. identified that in a population of
mechanically ventilated children, children 1-4 years of age required a significantly higher
dose of midazolam, starting on their first day of intubation, and other studies have
identified that age impacts both the pharmacokinetics and pharmacodynamics of
medications.(29-31)
This is one of the first studies to attempt to determine the incidence of this clinical
phenotype. Approximately 18% of subjects in the CART analysis demonstrated the
difficult-to-sedate outcome. Although this was one point on which the training and
validation data sets differed in the LCA, occurrence of the difficult-to-sedate child
phenotype was at a minimum 19%. This finding demonstrates that this clinical
phenotype is not rare. Combining the finding of the CART analysis that these children
tend to be young, and the concern that sedation medications may negatively impact
cognitive development, exploration of this clinical phenotype warrants further
investigation. Both the LCA and the CART analysis demonstrated these children require
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more classes of medication, and still are less likely to reach their target sedation goal as
demonstrated by the higher modal SBS scores for this group and the more frequent
incidence of inadequate sedation management events.
There are limitations to consider in this study. Although we used a rigorous
process to identify variables to include in the model, it is possible that we omitted an
important variable. The outcome variable used in the CART analysis was a composite
of two sedation related variables. It is possible that a different outcome variable would be
more appropriate. Secondary analyses of existing data sets presents some limitations.
Data collected may not include variables important to the question being investigated.
However, our question of interest generally fit the data available from the parent study.
The parent study was a cluster-randomized trial, with sites being randomized to
the intervention or control arms, so significant differences in sedation practices between
the control sites would impact study results. We carefully evaluated our data considering
treatment arm assignment and did find some significant differences, which could have
affected our findings. Young age, primary diagnosis, and primary opioid received were
important predictor variables in the CART analysis and there were significant differences
seen between the usual care and protocol groups in the parent study on these variables.
Subsequent prospective studies could address this limitation.
Sedation scores and medication data are key variables of interest in this study.
Low interrater reliability in sedation scoring would bias our results, particularly for the
CART analysis, as our outcome variable was a composite variable, which included a
sedation score. The parent trial assessed interrater reliability routinely throughout the
study, and demonstrated strong agreement with no difference in Fleiss’s kappa for the
SBS based on unit size or timing of assessment (earlier or later in the study).(32) The
parent study population included only children with acute respiratory failure, a subset of
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the PICU population, which limits generalizability of our findings. Missing data, which
may decrease power, was a concern, as approximately 9% of SBS scores were missing
for the study days in question and in the control group. This was particularly true in the
CART analysis, as SBS scores were part of the composite outcome variable. In
addition, other missing data points also decreased the final sample size.
Finally, other clinical entities, particularly tolerance, iatrogenic withdrawal
syndrome and delirium share some of the characteristics seen in the difficult-to-sedate
child. We felt that by examining data from days early in the clinical course, we would
avoid overlap with these potent confounders. We found that children were identified as
being positive for the difficult-to-sedate outcome variable beginning on their first day of
intubation and on average this group met the difficult to sedate criteria on two of the
days studied.
This study included primarily clinically observable characteristics in describing
this clinical phenotype, such as medication classes and doses received, sedation
scores, episodes of agitation, and level of consciousness. BUN and ALT were included
in the model, but no other biomarkers or genetic samples were included. This clinical
phenotype has not been previously described and the goal of this study was to
characterize the phenotype. However, it is likely that there is a genetic basis underlying
the clinical phenotype of the difficult-to-sedate child. There is emerging evidence that
polymorphisms in the cytochrome p450 enzymes may influence the metabolism of
benzodiazepines(33), and identifying a population at risk would facilitate investigation of
the genetic basis of this phenotype. The utility of characterizing this phenotype is that it
identifies a group of patients to target in a genome-wide association study.
Understanding the underlying genetic basis of the difficult-to-sedate clinical phenotype
would support early and appropriate medication selection and dosing.
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CONCLUSIONS
This study tested a model characterizing the difficult-to-sedate child and
identified that these children are typically young, require more adjunctive medications,
are more likely to have inadequate sedation management events, have high daily modal
SBS scores despite receiving high doses of opioids and benzodiazepines, have less
organ failure, particularly renal failure, and less need for vasoactive medications. In this
cohort of critically ill children, the incidence of this clinical phenotype was approximately
18%, indicating that this phenotype deserves further investigation. The next step would
be to test and refine this model using prospectively collected data.
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Table 1: Demographic and Patient Characteristics of Sample by Outcome First Three
Days of Therapy for the LCA & CART
LCA

CART
(N=2224)

n = 2449

Intervention group, No. (%)
Age at PICU admission, median
(IQR), years
Female, No., (%)
Non-Hispanic white, No., (%)
Baseline PCPC = 1, No., (%)
Baseline POPC = 1, No., (%)
PRISM III-12 score, median (IQR)
Primary diagnosis, No., (%)
Pneumonia
Bronchiolitis
Acute respiratory failure related
to sepsis
Asthma or reactive airway
disease
Aspiration pneumonia
Other
Past medical history, No., (%)
Prematurity
Previous exposure to
opioids/benzodiazepines
Oncology diagnosis
Chromosomal abnormality
Weight for age > 95th percentile, No.,
(%)
Pt characteristics PICU Days 0-3
Primary opioid agent, No., (%)
Morphine
Fentanyl
At least one modal SBS score
+1/+2, No., (%)
Opioid dose ≥0.2 mg/kg/hour
morphine equivalents any
day, No., (%)
Benzodiazepine dose ≥0.2
mg/kg/hour midazolam
equivalents any day, No., (%)
Highest number of secondary
sedative agents received any
day, median (IQR)

Not DTS
1976 (79)
985 (50)
2.0 (0.39.3)
880 (45)
1006 (51)
1503 (76)
1418 (72)
7 (3-13)

P value

666 (46)
725 (51)
1094 (76)
1024 (71)
8 (3-13)

DTS
473 (21)
240 (51)
1.6 (0.64.5)
221 (47)
227 (48)
362 (77)
329 (70)
7 (2-12)

493 (34)
424 (30)
200 (14)

179 (38)
110 (23)
49 (10)

647 (33)
547 (28)
308 (16)

0.03
0.05
0.003

121 (8)

59 (13)

148 (8)

<0.001

75 (5)
122 (9)

25 (5)
51 (11)

124 (6)
202 (10)

0.417
0.718

206 (14)
221 (15)
100 (7)
58 (4)

89 (18)
94 (20)

280 (14)
300 (15)

0.032
<0.001

161 (8)
86 (4)
263 (14)

0.113

324 (13)

30 (6)
22 (5)
61 (13)

487 (34)
918 (64)
218 (15)

105 (22)
362 (77)
166 (36)

728 (37)
1204 (69)
221 (11)

<0.001

343 (24)

358 (76)

240 (12)

<0.001

274 (17)

296 (63)

194 (10)

<0.001

0 (0)

1 (0-2)

0 (0-1)

<0.001

1.9 (0.4-8)

0.72
<.001
0.294
0.25
0.049
0.235
0.645

0.164

0.243
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Unplanned removal of any device,
No. of events, (%)
Inadequate sedation management
event
Received neuromuscular blockade
for agitation, No., (%)
BUN > 20, No., (%)
ALT > 55, No., (%)

38 (3)

15 (3)

42 (2)

0.255

141 (10)

166 (35)

122 (6)

<0.001

247 (17)

128 (27)

320 (16)

<0.001

233 (16)
356 (25)

55 (12)
69 (15)

328 (17)
440 (22)

0.026
0.001
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Table 2: Fit Statistics for Latent Class Models For 2 to 4 Class Models By Group
AIC

ABIC

Entropy

VLMR LRT

Percent of cohort per class

for k vs k-1
classes
(p-value)
1

2

3

57

43

17

42

41

29

22

33

19

81

19

36

45

28

24

18

4

Training Cohort
2 Classes

56799.9

57007.9

0.84

-29520.9
(<0.001)

3 Classes

54865.0

55177.1

0.91

-28302.0
(0.76)

4 Classes

57007.9

55177.1

0.88

-27285.5

16

(0.78)
Validation Cohort
2 Classes

37066.8

37233.4

.99

-19257.5
(<.001)

3 Classes

35966.6

36216.5

0.91

-18435.4
(0.78)

4 Classes

53894.6

35716.6

0.88

-17836.3

30

(0.78)
AIC= Akaike Information Criteria; ABIC= Sample-size Adjusted Bayesian Information Criteria;
VLMR LRT= Vuong-Lo-Mendell-Rubin Likelihood Ratio Test; Parametric BLRT= Parametric Bootstrapped Likelihood Ratio Test.
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Table 3: Test Characteristics of the Decision Tree
Characteristic
Number of subjects included

2078

Subjects positive for DTS

386

Number of true positives

32

Number of true negatives

646

Number of false positives

23

Number of false negatives

120

Accuracy (%, CI)

82.6 (0.799, 0.851)

Sensitivity

0.211

Specificity

0.966

Positive predictive value

0.582

Negative predictive value

0.843

Positive likelihood ratio

6.21

Negative likelihood ratio

0.82

Prevalence

0.067

CI= confidence interval; DTS= difficult-to-sedate
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Figures
Figure 1: Comparison of Latent Class and Classification and Regression Tree
Methodologies
Latent Class Analysis is a hypothesis-free statistical technique that uses mixture
modeling, and has been used extensively in clinical phenotype development studies to
identify unobserved (latent) classes by building typologies or clusters based on
observable variables within a data set. In comparison to other statistical analyses, no
outcome variable is included in the analysis. The algorithm seeks previously
unobserved patterns in the data by looking for patterns between the variables included
in the analysis, and produces groups of patients that are as different as possible from
each other. LCA works best with categorical or ordinal data. (13,14)

CART methodology is an exploratory data mining technique that searches large data
sets looking for meaningful patterns. It classifies populations into clinically meaningful
risk categories, and is useful in uncovering complex interactions when many potential
predictor variables and patterns of relationship exist. CART can use categorical,
ordinal and continuous data. Unlike LCA, CART does require an outcome or response
variable, which can be categorical or continuous. CART produces cut points and
ordering of decision nodes that clearly discriminate between groups with high and low
risk for the response variable. The CART output includes a diagram of the tree
produced by the analysis, which looks very similar to many algorithms used in clinical
care. (15-17)

LCA and CART are both non-parametric tests that do not require normally distributed
data. Both LCA and CART test statistical models, so multiple variations of the
proposed model are analyzed. The final best fitting model is selected based on model
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fit statistics and interpretability of the model. The model must then be validated by
testing the model in other groups to see if it is reproduced.(13-17)
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Figure 2: Latent Class Analysis Findings: Probability of Characteristics by Phenotype Assignment

Probability of Characteristics by Phenotype Assignment
Neuromuscular blockade for agitation
ISM any day
High SBS score any day
Require adjunctive medications
Hepatic failure
BUN >20
Require vasoactive medications
History of asthma
Abnormal LOC
Abnormal POPC
Abnormal PCPC
0.00

0.10

0.20

0.30
DTS

0.40

0.50

0.60

0.70

0.80

Not DTS

BUN= blood urea nitrogen in mg/dL; ISM= inadequate sedation management event; LOC= level of consciousness; PCPC= Pediatric
Cerebral Performance Category; POPC= Pediatric Overall Performance Category
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Figure 3: Classification and Regression Tree Decision Tree for Difficult-to-Sedate Child Clinical Phenotype

BUN= blood urea nitrogen; DTS= difficult-to-sedate; ISM= inadequate sedation management event; # 3rd agents= number of
classes of adjunctive medications received; SBS= State Behavioral Scale Score.
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Supplement 1
Table 1: Variables included in the Difficult-to-Sedate Analysis Linked to Survey of Expert
PICU Clinicians
Sedation Characteristics

LCA Variable

CART Variable

Requires 3 or more sedation

Received 3rd class of

Number of classes of

classes simultaneously

sedation medication

additional sedation
medication received

Daily modal SBS +1/+2

Modal SBS score +1/+2

Modal SBS score +1/+2

any day 0-3

any day 0-3

SBS +1/+2 for 2 consecutive

Inadequate sedation

Inadequate sedation

hours

management event

management event

Doses >90th percentile of usual

Morphine or midazolam

Element in composite

starting dose

equivalents ≥0.2

outcome variable

mg/kg/hour
Intermittent paralytic doses for

Received neuromuscular

Received

sedation

blockade for agitation

neuromuscular
blockade for agitation

Sedation-related Events
Suspected delirium

Number of events too

Number of events too

small to include in

small to include in

analysis

analysis

Unplanned endotracheal

Unplanned device

Unplanned

extubation

Removal

endotracheal tube
removal
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Unplanned removal of an

Unplanned device

Unplanned device

invasive device

removal

removal

Paradoxical response to

Number of events too

Number of events too

sedation

small to include in

small to include in

analysis

analysis

Demographic/Diagnostic Characteristics
Trisomy 21

PRISM III-12

PRISM III-12

chromosomal

chromosomal

abnormality

abnormality

Past medical history of

Past medical history of

previous exposure

previous exposure

Not able to verbally

PCPC

PCPC

communicate

GCS

GCS

LOC

LOC

Overweight for age

BMI

Normal BMI

Weight for Age

PRISM III-12 cancer

PRISM III-12 cancer

diagnosis

diagnosis

PCPC

PCPC

POPC

POPC

Admission Diagnosis

Admission Diagnosis

Previous sedation exposure

>90th percentile for BMI

Oncologic diagnosis

Moderate or severe cerebral
disability
Moderate or severe overall
disability
Bronchiolitis

Additional Variables Suggested by Experts
Prematurity

History of prematurity

History of prematurity
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Infant or toddler

Age category

Age

Patient instability

PRISM III-12 Z-score

PRISM III-12 Z-score

Vasoactive medications

Vasoactive medications

Cardiovascular, hepatic,

Cardiovascular, hepatic,

renal, neurologic failure

renal, neurologic failure

Elevated BUN or ALT

Elevated BUN or ALT

Admission diagnosis

Admission diagnosis

Asthma diagnosis

Asthma diagnosis

Seizure disorder

Seizure disorder

Diagnosis specific

Additional factors suggested in the literature
Gender

Gender

Gender

Race/ethnicity

Race, ethnicity

Race, ethnicity

Primary opioid (morphine vs.

Primary opioid days 0-3

Primary opioid days 0-3

fentanyl)
GCS= Glasgow Coma Scale score; LOC= level of consciousness; PRISM III-12 =
PCPC= Pediatric Cerebral Performance Score; POPC= Pediatric Overall Performance
Score;
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Supplement Table 2: Characteristics of the Parent Study Cohort by Group
Admission Characteristics
Age at PICU admission, median (IQR),
years
Female, No. (%)
Non-Hispanic white, No. (%)
Baseline PCPC = 1, No. (%)
Baseline POPC = 1, No. (%)
PRISM III-12 score, median (IQR)
Primary diagnosis, No. (%)
Pneumonia
Bronchiolitis
Acute respiratory failure related to
sepsis
Asthma or reactive airway disease
Aspiration pneumonia
Other
Past medical history, No. (%)
Prematurity
Previous exposure to
opioids/benzodiazepines
Oncology diagnosis
Chromosomal abnormality
Weight for age > 95th percentile, No. (%)
Pt characteristics PICU Days 0-3
Primary opioid agent, No. (%)
Morphine
Fentanyl
Other
None
At least one modal SBS score +1/+2,
No. (%)
Opioid dose ≥0.2 mg/kg/hour
morphine equivalents any day,
No. (%)
Benzodiazepine dose ≥0.2
mg/kg/hour
midazolam equivalents
any day, No. (%)
Highest number of secondary
sedative agents received any
day,
median (IQR)
Unplanned removal of any device,
No. of events, (%)
Inadequate sedation management
event, No., (%)
Received neuromuscular blockade for
agitation, No., (%)
BUN > 20, No., (%)

Total

Control

Intervention

p value

n = 2449
1.8 (0.48.2)
1,101
(45)
1,233
(50)
1,865
(76)
1,747
(71)
7 (3-13)

n = 1224
2.6 (0.69.2)
543 (44)

n = 1225
1.4 (0.3-7.0)

0.002

558 (46)

0.53

602/1210
(50)
923 (75)

631/1215 (52)

0.81

942 (77)

0.41

862 (70)

885 (72)

0.51

8 (5-13.5)

6 (3-11)

0.005

827 (34)
656 (27)
357 (15)

433 (35)
228 (19)
212 (17)

394 (32)
428 (35)
145 (12)

<0.001

207 (8)
149 (6)
253 (10)

120 (10)
79 (6)
152 (12)

87 (7)
70 (6)
101 (8)

369
394

0.37

197 (8)
108 (4)
307 (13)

109 (9)
48 (4)
144 (12)

88 (7)
60 (5)
163 (13)

0.31
0.24
0.132

992 (41)
1,420
(58)
13 (<1)
24 (1)
387 (16)

210 (17)
989 (81)
10 (<1)
15 (1)

782 (64)
431 (35)
3 (<1)
9 (<1)

242 (20)

145 (12)

0.002

588 (24)

334 (28)

254 (21)

0.001

490 (20)

276 (23)

214 (17)

0.002

0 (0-1.0)

0 (0-1.0)

0 (0-1.0)

<0.001

59 (2)

31 (3)

28 (2)

0.685

547 (22)

246 (20)

301 (25)

0.93

616 (25)

326 (27)

290 (24)

0.66

403 (16)

233 (19)

170 (14)

<0.001

<0.001
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ALT > 55, No., (%)

404 (16)

230 (19)

174 (14)

<0.001

ALT= alanine amino transferase; BUN= blood urea nitrogen in mg/dL; IQR= interquartile
range; PCPC= Pediatric Cerebral Performance Category; POPC= Pediatric Overall
Performance Category; PRISM III-12= Pediatric Risk of Mortality version III score for first
12 hours of PICU admission; SBS= State Behavioral Scale score.
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Supplement Figure 1: CART Variable Importance

BMI= body mass index; BUN= blood urea nitrogen; ISM= inadequate sedation
management event; No. 3rd agents= number of classes of adjunctive medications
received; SBS= State Behavioral Scale Score.
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CHAPTER 5
DISCUSSION AND CONCLUSIONS
Sedation of critically ill children is one of the most commonly provided therapies
in PICUs, yet clinicians continue to search for the optimal way to provide this therapy. It
requires a delicate balance between providing sufficient sedation to ensure the child is
comfortable and able to tolerate needed interventions such as endotracheal intubation
and mechanical ventilation, yet not so much that the child is at risk for iatrogenic injury
and a prolonged length of mechanical ventilation or stay due to oversedation. The
majority of sedative drugs used in the PICU are used off-label. They have not been
studied extensively in children, and dosing guidelines are often extrapolated from adult
studies.(1) Chapters 1 and 2 of this dissertation describe variability of current practice,
nationally and internationally, in terms of sedative agents used, methods of assessment
of the level of sedation, and the use of non-pharmacologic techniques such as noise
reduction and promoting normal day/night cycling.(2,3)
PICU patients are a very heterogeneous population and this increases the
complexity of providing optimal sedation to all patients. Patients range in age from birth
to 18 years with a wide variety of diagnoses, and evidence suggests that age and critical
illness impact the pharmacokinetics and pharmacodynamics of sedation medications.
(4,5) Young children do not yet have the developmental skills needed to cognitively
appraise and understand the PICU environment. In addition, there is recent evidence
suggesting that sedatives routinely used in the PICU may have a negative impact on
neurodevelopment in young children.(6,7) As a result, clinical practice is trending toward
setting sedation goals of a more awake state, and the decreased use of
benzodiazepines, with the concomitant increase in the use of other sedative agents.
These concerns are descriptive of the PICU population as a whole, but there is
an added level of complexity in providing sedation to patients in the PICU, due to
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significant inter-patient variability in response to sedation medications. In particular,
some children remain consistently agitated despite receiving high doses and multiple
classes of sedative agents. These children are frequently labeled difficult-to-sedate.
Studies have acknowledged the existence of this population, but this group has not been
well described or studied. This dissertation contributes to the existing knowledge of
sedation for critically ill children by creating and testing an operational definition of the
difficult-to-sedate child clinical phenotype, which will be useful in future research.
Overall Goals
The purpose of this study was to explore and define the phenomenon of the
difficult-to-sedate child clinical phenotype within a population of critically ill children. This
is one of the first studies attempting to operationalize this concept and identify its
prevalence. The study had three specific aims: (1) to explore key variables thought to
be associated with the difficult-to-sedate child and propose a conceptual model linking
those variables in critically ill pediatric patients; (2) to assess both face and content
validity of the candidate variables identified in the difficult-to-sedate conceptual model;
and (3) to build and test a statistical model describing the difficult-to-sedate child clinical
phenotype. The conceptual model, described in Chapter 2, served as the foundation for
the subsequent analyses. Chapter 3 details the process of establishing face and content
validity of the variables included in the model, and Chapter 4 details the modeling
process. In this exploratory analysis, the majority of variables included in the statistical
model performed consistently across the two methods of analysis, providing further
support for the conceptual model. The results of this study show that the difficult-tosedate child clinical phenotype is a stable concept, and may represent 18% of the PICU
patient population.
Major Findings: Operational Definition
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The difficult-to-sedate child is one who requires routine and repeated escalation
of sedation doses beginning on the first day of intubation, routine administration of
adjunctive sedation medications over and above the increased opioid and
benzodiazepine doses, and reaches opioid and benzodiazepine doses above the unit’s
standard range for the drug within the first three days of intubation without achieving the
target sedation goal.
Prior to the definition proposed in this dissertation, no clear operational definition
of the difficult-to-sedate clinical phenotype existed in the pediatric critical care literature.
Variability in practice is one of the main reasons for this. There are several different
assessment instruments used to identify the child’s level of sedation, many of which lack
sufficient reliability and validity testing. Some tools, such as the COMFORT B (8) assess
both pain and agitation, using a single score. This can be problematic for the clinician at
the bedside who must use a single score to determine whether pain or anxiety is the
cause of a child’s distress and then select the appropriate intervention for the child
receiving both analgesics and opioids.
Another reason an operational definition is lacking is that routine establishment of
a daily sedation goal does not occur in most PICUs. Kudchadkar et al. surveyed an
international group of pediatric intensivists in 2014 and identified that although 70% of
units reported using a specific sedation assessment instrument, less than half of those
units used them regularly to establish a daily sedation goal to guide therapy.(3) More
recently, Garcia Guerra et al. (2) surveyed Canadian pediatric critical care intensivists on
the same topic and found that 74% of PICUs did not routinely identify a daily sedation
goal. Without designation of a goal and routine assessment of goal achievement, there
is no objective way to determine when a child is optimally or sub optimally sedated.
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The studies included in the literature review detailed in Chapter 2 consisted of
seven that assessed the effectiveness of a sedation protocol, 12 that compared two
different sedation medications or assessed the effectiveness of a single drug and 10 that
assessed the accuracy of an “objective” sedation measure, most commonly the
Bispectral index monitor. All but two of the studies described patients who were
undersedated, but used a wide variety of metrics. A frequently used metric was the
number of observations where a child was above the desired sedation goal. As detailed
in Chapter 2, number of episodes of agitation, removal of a patient from study due to
“treatment failure”, percent of total drug administration time the child was in the target
sedation range and percent of time a child was undersedated based on a set sedation
goal were other metrics described. The variability seen here clearly identifies the lack of
a consistent operational definition. It is interesting that the studies evaluating drug
effectiveness and the effectiveness of sedation protocols did not use a consistent metric
to report the observed rate of undersedation, as this limits the ability to compare
treatment protocols.
The operational definition created through the process of concept analysis
included several characteristics: routine and repeated escalation of sedation doses
beginning on the first day of intubation, routine administration of adjunctive sedation
medications over and above the increased opioid and benzodiazepine doses, and
reaches opioid and benzodiazepine doses above the unit’s standard range for the drug
within the first three days of intubation without achieving the target sedation goal. Young
age and Trisomy 21 were the two demographic characteristics identified through the
literature review. When considering use of this operational definition, it is important to
note that obtaining sedation scores, setting a sedation score goal, knowledge of the
standard dose specific to the PICU where the child is receiving care, and knowledge of
159

adjunctive medication are key elements that must be in place. Utilization of this
definition across studies in this population will facilitate comparison of results.
Major Findings: Face and Content Validity of the Operational Definition
Chapter 3 describes the process used to establish face and content validity for
the 17 candidate variables identified through the literature review. The survey was
distributed via email to 411 expert pediatric critical care clinicians, primarily physicians,
from 61 centers across the U.S. The response rate was 29%, and 69% of sites were
represented. The amount of missing data was minimal, at 0.3%. Respondents scored
each of the candidate variables using a rating of 1 (not at all relevant) to 4 (highly
relevant). An item level content validity index (I-CVI) was calculated for each variable,
and items with an I-CVI≥0.70 were considered important and retained in the model.
The participants agreed that the majority of candidate variables proposed were
characteristic of the difficult-to-sedate child. The 10 variables confirmed for inclusion in
the final model were as follows: requiring three or more sedation classes simultaneously,
a daily modal State Behavioral Scale (SBS) score indicating agitation (SBS +1/+2), an
SBS score indicating agitation for 2 consecutive hours, receiving sedatives at a dose
>90th percentile of the usual starting dose, receiving intermittent paralytic doses for
sedation, suspected delirium, unplanned endotracheal extubation, unplanned removal of
an invasive device, paradoxical response to sedation, and Trisomy 21. Six items which
had a low I-CVI were demographic characteristics: not able to verbally communicate,
>90th percentile for BMI, oncologic diagnosis, moderate or severe cerebral disability,
moderate or severe overall disability, and bronchiolitis. The highest-rated item was
requiring three or more sedation classes simultaneously. Additional characteristics were
proposed by the respondents, with young age being most consistently cited. Additional
variables included in the final model based on expert feedback were medical diagnosis
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and required multiple sedative agents. In summary, expert clinicians validated that the
majority of variables extracted from the literature were appropriate to include in the final
model, along with two additional variables.
Major Findings: Characteristics of the Difficult-to-sedate Clinical Phenotype
Latent Class Analysis (LCA) was used to identify the model which best divided
the group into clinically meaningful classes. LCA provides a description of members of
each class by indicating the probability that they will be positive for any variable. High
probability supports inclusion of the variable as class-defining. Evaluation of model fit
statistics and interpretability identified a two-class model as the best fitting model, with
classes identified as difficult-to-sedate and not difficult-to-sedate. Variables which had a
high probability of being true for the class were identified as characteristic of the difficultto-sedate class. Variables with the highest probabilities and the widest separation from
the not difficult-to-sedate class included the need for adjunctive medications, less organ
failure, higher incidence of inadequate sedation events, and normal cognitive state. The
not difficult-to-sedate class had a low probability for each of these variables. Repeating
the analysis using the validation cohort demonstrated that the model was stable across
the cohorts. The probabilities identified in the testing cohort were found to be similar in
the validation cohort, with the exception of probability of class membership. Individuals
in the testing cohort had a 43% probability of belonging to the difficult-to-sedate class,
while individuals in the validation cohort had a 19% chance of belonging to the difficultto-sedate class. The characteristics of the difficult-to-sedate class are consistent and
supported in both cohorts. The proportion of individuals belonging to the difficult-tosedate class were different across the two cohorts, and further testing using different
sized training and validation cohorts would better define the size of the difficult-to-sedate
population.
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Major Findings: Variables Indicating Risk for the Outcome of Difficult-to-sedate
CART analysis was used to identify patients at risk of being difficult-to-sedate.
As detailed in Paper 3 (Chapter 4), CART sorts patients on each of the predictor
variables included in the model. Unlike LCA, CART requires an outcome variable. Based
on the literature review and I-CVIs established by the group of critical care experts, a
composite difficult-to-sedate binary categorical outcome variable was created. In order
for a subject to be scored as positive for the outcome, two criteria had to be met: the
SBS score had to be +1/+2 and the subjected had to have received at least two times
the starting dose of an opioid or benzodiazepine continuous infusion on any study day
from day 0-3.
The output of a CART analysis includes a decision tree and various fit statistics,
which are described in detail in Chapter 4. Variables which identified a patient as at risk
for being difficult to sedate included need for adjunctive sedation medications, daily
modal SBS score of +1/+2, occurrence of an inadequate sedation management event,
presence of an elevated blood urea nitrogen (BUN) level, age, weight, and race.
Sensitivity and specificity are important indicators of a useful decision tree, as
they indicate whether a subject was placed into the appropriate category. Each of the
analyses demonstrated good specificity, correctly identifying difficult-to-sedate patients
94% of the time. However sensitivity was low, resulting in patients being classified as
difficult-to-sedate when in fact they were not positive for any of the indicator variables.
Major Findings: Characteristics Identifying the Difficult-to-sedate Clinical
Phenotype
Regardless of the methodology used, some characteristics were important
indicators of this group, and aligned with expert opinion. The requirement for adjunctive
medications, presence of organ failure, particularly renal failure, occurrences of
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inadequate sedation management events, high daily modal SBS scores and need for
vasoactive medications were sorting characteristics in both CART and LCA. CART also
identified young age and primary diagnosis as important predictor variables, which align
with our conceptual model and the opinion of experts. The results of these analyses
provide support for the operational definition proposed in Paper 1. Approximately 18% of
patients demonstrated the difficult-to-sedate outcome, based on the operational
definition of difficult-to-sedate. This is one of the first studies attempting to determine the
incidence of this clinical phenotype. Although it is difficult to extrapolate an expected rate
of incidence from the literature reviewed, our finding does not seem excessively high.
Limitations
This study was a secondary analysis of an existing data set, and it is likely that
characteristics important to our concept were not included or available in the RESTORE
data set. Missing data had an impact on the data analysis. Sedation assessment was a
key variable, and 9% of subjects were missing SBS scores on all days. Because SBS
scores contributed to the composite outcome variable created for the CART analysis,
subjects who did not have SBS scores recorded on days 0 - 3 could not be included in
the CART analysis. As a result, the incidence of the difficult-to-sedate clinical phenotype
reported here might have been mis-estimated. It is important to note that overall, the
data from RESTORE was of high quality, as sites routinely assessed inter-rater reliability
for the SBS score and demonstrated high reliability.
A major assumption of this study was that pain was adequately controlled in this
population. It is possible that this was not the case, especially early in the patient’s
course of treatment which was the timeframe evaluated in this study. The patients
enrolled in RESTORE primarily had medical diagnoses, as opposed to surgical
diagnoses, so it is less likely that pain was a highly significant issue for this group.
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However, because patients did have medical diagnoses, the generalizability of our
findings is limited.
Achieving optimal sedation is a very complex process, involving more than the
child’s clinical phenotype. The conceptual model described in Paper 1 indicates that in
addition to child specific factors, process and environmental factors also influence
sedation outcomes. This study focused exclusively on patient level factors in describing
the difficult-to-sedate clinical phenotype, which is a simplistic approach given that
phenotype is a set of observable characteristics created through the interaction of the
individual’s genotype with the environment. In future studies, it will be important to
evaluate the impact of environmental and process factors.
Finally, this exploratory study employed a very straightforward approach to
machine learning techniques. Testing a more complex model using covariates might
help to refine the model and improve sensitivity.
Directions for Future Research
The majority of critically ill children in PICUs require mechanical ventilation, and
therefore receive sedation. Establishing the clinical phenotype of the difficult-to-sedate
child and its incidence in a cohort of children supports the necessity for continued work
in this area, as there are physiologic, developmental, psychosocial and economic
impacts resulting from undersedation. This study raises many new questions and
suggests multiple areas for investigation.
It is necessary to replicate the findings from this study prospectively in other
populations. For example, this study identified the incidence of the difficult-to-sedate
child clinical phenotype as approximately 13%. It will be important to examine this
statistic in other patient populations, in order to determine the true incidence. It will also
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be important to validate the characteristics and risk factors described in this study in
other cohorts of critically ill children.
The characteristics included in this model were theoretically determined and then
validated through a survey of practicing PICU clinicians, primarily physicians, prior to
testing. Nurses are also intricately involved in providing sedation to critically ill children
and monitoring the outcome. It would be useful to explore this model with nurses
experienced in providing sedation to critically ill children, in order to continue to develop
and refine the model.
An important area for future investigation is exploring a genetic basis for this
phenotype. Phenotypes are observed characteristics of the individual that result from the
interaction of the genotype, the environment, and other factors. Clinical phenotypes are
useful specifically because they are observable. Examining the genomes of a group of
individuals presenting with a particular observed trait such as an unexpected response
to sedation increases the likelihood that a genome-wide association study (GWAS) could
identify genetic variants that contribute to the altered drug response. A well-defined
phenotype that clearly identifies affected individuals enhances the effectiveness of a
well-designed GWAS.
Examining the genomes of phenotypic individuals through a GWAS has been
used successfully to identify specific families of genes in the cytochrome P450 enzyme
system, which characterize individuals in terms of their metabolism of codeine and other
pain and sedation medications (9). Genetic polymorphisms cause intra-individual
variation in enzyme activity, resulting in varying rates of drug metabolism, expressed as
different phenotypes. Two groups of particular concern have been labeled poor
metabolizers and ultra-rapid metabolizers as those individuals do not process drug in the
“typical” way and are at risk for adverse drug reactions. Commercially available assays
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that test for these specific polymorphisms exist and are becoming more affordable, and
as a result are beginning to be utilized in clinical practice.(10).
The CYP3A4 enzyme, part of the cytochrome P450 enzyme system has been
linked to the action of midazolam and other benzodiazepines.(11) Identifying the
particular genetic variant responsible for differing action in different individuals would
support clinical care in a variety of ways. Clinicians currently base initial drug dosing of
sedatives on a standard dose known to be effective for the majority of patients and
adjust the dose as needed based on the patient’s response. Multiple dose adjustments
over an extended period may be required to achieve the target sedation level in a patient
with an atypical response. The undersedated child remains at risk for iatrogenic injury
until the correct drug and dose are identified. Knowledge of the patient’s genotype
specific response to sedation medications would allow individualization of both the drug
selected and the appropriate dose. In addition to quickly achieving the desired sedation
level, the patient would not be exposed to drugs known to be ineffective for their
genotype. This is particularly important in light of the current concern related to
neurotoxic effects of sedatives on the developing brain.(12,13)
Conclusion
The three papers developed in this dissertation study explored the concept of the
difficult-to-sedate child clinical phenotype and accomplished three objectives. A
comprehensive review of the literature identified the lack of an operational definition and
facilitated extraction of possible factors contributing to the clinical phenotype. These
factors were used to provide an initial operational definition and construct a conceptual
model. A panel of expert critical care clinicians validated the elements of the operational
definition through an assessment of face and content validity and proposed additional
factors to be included in the model. A refined definition was tested using data from the
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RESTORE study. The characteristics identified through latent class analysis were
similar to risk factors identified through classification and regression tree analysis, and
consistent with the conceptual model proposed.
Decreasing the ambiguity that currently exists around the concept of the difficultto-sedate child clinical phenotype is a major achievement of this study. A clear
operational definition of the concept promotes its consistent measurement and facilitates
future investigation. This definition can be utilized by other researchers, allowing useful
comparisons across studies. The conceptual model and operational definition
developed in this study require further investigation and refinement, as well as validation
by other investigators. This study suggests that a clinically meaningful population of
difficult-to-sedate children requiring mechanical ventilation for a critical illness exists.
Documentation of this phenotype promotes the development of evidence on the best
way to support these children. Critically ill difficult-to-sedate children and their families
will benefit from future research exploring this question.
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